| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP-dependent chromatin remodeler activity | 2.86e-12 | 37 | 48 | 7 | GO:0140658 | |
| GeneOntologyMolecularFunction | structural constituent of cytoskeleton | 7.87e-10 | 130 | 48 | 8 | GO:0005200 | |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on DNA | 2.11e-08 | 127 | 48 | 7 | GO:0008094 | |
| GeneOntologyMolecularFunction | helicase activity | 9.53e-08 | 158 | 48 | 7 | GO:0004386 | |
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | TAS2R14 NPY5R OR4A15 ESR1 OR6C75 OR4C46 OR10A6 OR5K2 TAAR1 ADGRV1 OR5K1 OR4X1 | 8.40e-07 | 884 | 48 | 12 | GO:0004930 |
| GeneOntologyMolecularFunction | guanyl ribonucleotide binding | TUBA1B RANBP1 TUBA1A TUBA3D TUBA1C TUBA3E TUBA8 TUBA4A TUBA3C | 8.67e-07 | 439 | 48 | 9 | GO:0032561 |
| GeneOntologyMolecularFunction | guanyl nucleotide binding | TUBA1B RANBP1 TUBA1A TUBA3D TUBA1C TUBA3E TUBA8 TUBA4A TUBA3C | 8.67e-07 | 439 | 48 | 9 | GO:0019001 |
| GeneOntologyMolecularFunction | catalytic activity, acting on DNA | 2.87e-06 | 262 | 48 | 7 | GO:0140097 | |
| GeneOntologyMolecularFunction | histone binding | 3.10e-06 | 265 | 48 | 7 | GO:0042393 | |
| GeneOntologyMolecularFunction | GTP binding | 4.28e-06 | 397 | 48 | 8 | GO:0005525 | |
| GeneOntologyMolecularFunction | nuclear steroid receptor activity | 2.89e-05 | 25 | 48 | 3 | GO:0003707 | |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | TAS2R14 NPY5R OR4A15 ESR1 OR6C75 OR4C46 OR10A6 OR5K2 TAAR1 ADGRV1 OR5K1 OR4X1 | 6.32e-05 | 1353 | 48 | 12 | GO:0004888 |
| GeneOntologyMolecularFunction | olfactory receptor activity | 7.13e-05 | 431 | 48 | 7 | GO:0004984 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | 9.73e-05 | 614 | 48 | 8 | GO:0140657 | |
| GeneOntologyMolecularFunction | zinc ion binding | 2.35e-04 | 891 | 48 | 9 | GO:0008270 | |
| GeneOntologyMolecularFunction | estrogen response element binding | 3.07e-04 | 11 | 48 | 2 | GO:0034056 | |
| GeneOntologyMolecularFunction | chromatin binding | 3.44e-04 | 739 | 48 | 8 | GO:0003682 | |
| GeneOntologyMolecularFunction | transcription coregulator binding | 3.55e-04 | 140 | 48 | 4 | GO:0001221 | |
| GeneOntologyMolecularFunction | nuclear receptor activity | 4.05e-04 | 60 | 48 | 3 | GO:0004879 | |
| GeneOntologyMolecularFunction | ligand-activated transcription factor activity | 4.25e-04 | 61 | 48 | 3 | GO:0098531 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | 6.28e-04 | 441 | 48 | 6 | GO:0016887 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on a nucleic acid | 8.27e-04 | 645 | 48 | 7 | GO:0140640 | |
| GeneOntologyMolecularFunction | methylated histone binding | 1.16e-03 | 86 | 48 | 3 | GO:0035064 | |
| GeneOntologyMolecularFunction | structural molecule activity | 1.18e-03 | 891 | 48 | 8 | GO:0005198 | |
| GeneOntologyMolecularFunction | methylation-dependent protein binding | 1.24e-03 | 88 | 48 | 3 | GO:0140034 | |
| GeneOntologyMolecularFunction | modification-dependent protein binding | 1.50e-03 | 206 | 48 | 4 | GO:0140030 | |
| GeneOntologyMolecularFunction | transition metal ion binding | 1.86e-03 | 1189 | 48 | 9 | GO:0046914 | |
| GeneOntologyMolecularFunction | lysine-acetylated histone binding | 2.36e-03 | 30 | 48 | 2 | GO:0070577 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | 2.37e-03 | 775 | 48 | 7 | GO:0017111 | |
| GeneOntologyMolecularFunction | acetylation-dependent protein binding | 2.52e-03 | 31 | 48 | 2 | GO:0140033 | |
| GeneOntologyMolecularFunction | nuclear androgen receptor binding | 2.85e-03 | 33 | 48 | 2 | GO:0050681 | |
| GeneOntologyMolecularFunction | TBP-class protein binding | 2.85e-03 | 33 | 48 | 2 | GO:0017025 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | 3.69e-03 | 839 | 48 | 7 | GO:0016462 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | 3.72e-03 | 840 | 48 | 7 | GO:0016817 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | 3.72e-03 | 840 | 48 | 7 | GO:0016818 | |
| GeneOntologyMolecularFunction | transcription coactivator activity | 5.99e-03 | 303 | 48 | 4 | GO:0003713 | |
| GeneOntologyMolecularFunction | core promoter sequence-specific DNA binding | 7.75e-03 | 55 | 48 | 2 | GO:0001046 | |
| GeneOntologyMolecularFunction | transcription corepressor binding | 8.87e-03 | 59 | 48 | 2 | GO:0001222 | |
| GeneOntologyMolecularFunction | transcription factor binding | 8.98e-03 | 753 | 48 | 6 | GO:0008134 | |
| GeneOntologyMolecularFunction | nuclear receptor binding | 1.03e-02 | 187 | 48 | 3 | GO:0016922 | |
| GeneOntologyMolecularFunction | general transcription initiation factor binding | 1.04e-02 | 64 | 48 | 2 | GO:0140296 | |
| GeneOntologyBiologicalProcess | microtubule cytoskeleton organization | TUBA1B RANBP1 TUBA1A TUBA3D TUBA1C TUBA3E CCN2 CHD3 TUBA8 TUBA4A TUBA3C | 7.54e-07 | 720 | 49 | 11 | GO:0000226 |
| GeneOntologyBiologicalProcess | mitotic cell cycle | TUBA1B RANBP1 TUBA1A TUBA3D ESR1 TUBA1C SMARCA2 SMARCA4 TUBA3E TUBA8 TUBA4A TUBA3C | 3.19e-06 | 1014 | 49 | 12 | GO:0000278 |
| GeneOntologyBiologicalProcess | chromatin organization | KDM4C ESR1 SMARCA2 SMARCA4 CHD9 CHD8 CHD3 CHD6 NR3C1 ZZEF1 HELLS | 6.26e-06 | 896 | 49 | 11 | GO:0006325 |
| GeneOntologyBiologicalProcess | chromatin remodeling | 7.78e-06 | 741 | 49 | 10 | GO:0006338 | |
| GeneOntologyBiologicalProcess | detection of stimulus involved in sensory perception | TAS2R14 OR4A15 OR6C75 OR4C46 OR10A6 OR5K2 ADGRV1 OR5K1 OR4X1 | 8.00e-06 | 582 | 49 | 9 | GO:0050906 |
| GeneOntologyBiologicalProcess | G protein-coupled receptor signaling pathway | TAS2R14 NPY5R OR4A15 ESR1 OR6C75 OR4C46 OR10A6 DGKG OR5K2 TAAR1 ADGRV1 OR5K1 OR4X1 | 1.55e-05 | 1395 | 49 | 13 | GO:0007186 |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception | 1.71e-05 | 485 | 49 | 8 | GO:0050907 | |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | KDM4C ESR1 SMARCA2 SMARCA4 CHD9 CHD8 CHD3 CHD6 NR3C1 ZZEF1 HELLS | 1.74e-05 | 999 | 49 | 11 | GO:0071824 |
| GeneOntologyBiologicalProcess | microtubule-based process | TUBA1B RANBP1 TUBA1A TUBA3D TUBA1C TUBA3E CCN2 CHD3 TUBA8 TUBA4A TUBA3C | 2.96e-05 | 1058 | 49 | 11 | GO:0007017 |
| GeneOntologyBiologicalProcess | detection of chemical stimulus | 2.97e-05 | 524 | 49 | 8 | GO:0009593 | |
| GeneOntologyBiologicalProcess | steroid hormone receptor signaling pathway | 3.28e-05 | 155 | 49 | 5 | GO:0043401 | |
| GeneOntologyBiologicalProcess | sensory perception of chemical stimulus | 4.02e-05 | 547 | 49 | 8 | GO:0007606 | |
| GeneOntologyBiologicalProcess | detection of stimulus | TAS2R14 OR4A15 OR6C75 OR4C46 OR10A6 OR5K2 ADGRV1 OR5K1 OR4X1 | 4.39e-05 | 722 | 49 | 9 | GO:0051606 |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception of smell | 6.77e-05 | 432 | 49 | 7 | GO:0050911 | |
| GeneOntologyBiologicalProcess | aortic smooth muscle cell differentiation | 8.24e-05 | 6 | 49 | 2 | GO:0035887 | |
| GeneOntologyBiologicalProcess | regulation of miRNA metabolic process | 1.05e-04 | 103 | 49 | 4 | GO:2000628 | |
| GeneOntologyBiologicalProcess | sensory perception of smell | 1.07e-04 | 465 | 49 | 7 | GO:0007608 | |
| GeneOntologyBiologicalProcess | regulation of G0 to G1 transition | 1.36e-04 | 42 | 49 | 3 | GO:0070316 | |
| GeneOntologyBiologicalProcess | G0 to G1 transition | 1.56e-04 | 44 | 49 | 3 | GO:0045023 | |
| GeneOntologyBiologicalProcess | miRNA metabolic process | 1.83e-04 | 119 | 49 | 4 | GO:0010586 | |
| GeneOntologyBiologicalProcess | cellular response to steroid hormone stimulus | 2.52e-04 | 239 | 49 | 5 | GO:0071383 | |
| GeneOntologyBiologicalProcess | hormone-mediated signaling pathway | 2.77e-04 | 244 | 49 | 5 | GO:0009755 | |
| GeneOntologyBiologicalProcess | positive regulation of myoblast differentiation | 2.87e-04 | 54 | 49 | 3 | GO:0045663 | |
| GeneOntologyBiologicalProcess | nuclear receptor-mediated steroid hormone signaling pathway | 3.04e-04 | 136 | 49 | 4 | GO:0030518 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | ZBTB38 KDM4C ESR1 SMARCA2 SMARCA4 CHD8 CHD6 ZNF841 NR3C1 NR1D1 ZNF292 | 3.37e-04 | 1390 | 49 | 11 | GO:0045944 |
| GeneOntologyBiologicalProcess | cellular response to organic cyclic compound | 5.32e-04 | 605 | 49 | 7 | GO:0071407 | |
| GeneOntologyBiologicalProcess | positive regulation of miRNA metabolic process | 6.97e-04 | 73 | 49 | 3 | GO:2000630 | |
| GeneOntologyBiologicalProcess | sensory perception | TAS2R14 OR4A15 OR6C75 OR4C46 OR10A6 OR5K2 ADGRV1 OR5K1 OR4X1 | 8.39e-04 | 1072 | 49 | 9 | GO:0007600 |
| GeneOntologyBiologicalProcess | glial cell differentiation | 9.63e-04 | 321 | 49 | 5 | GO:0010001 | |
| GeneOntologyBiologicalProcess | transcription initiation at RNA polymerase II promoter | 9.88e-04 | 186 | 49 | 4 | GO:0006367 | |
| GeneOntologyBiologicalProcess | regulation of miRNA transcription | 1.01e-03 | 83 | 49 | 3 | GO:1902893 | |
| GeneOntologyBiologicalProcess | regulation of protein kinase C signaling | 1.02e-03 | 20 | 49 | 2 | GO:0090036 | |
| GeneOntologyBiologicalProcess | miRNA transcription | 1.05e-03 | 84 | 49 | 3 | GO:0061614 | |
| GeneOntologyBiologicalProcess | regulation of intracellular steroid hormone receptor signaling pathway | 1.16e-03 | 87 | 49 | 3 | GO:0033143 | |
| GeneOntologyCellularComponent | microtubule | 2.61e-05 | 533 | 48 | 8 | GO:0005874 | |
| GeneOntologyCellularComponent | bBAF complex | 2.30e-04 | 10 | 48 | 2 | GO:0140092 | |
| GeneOntologyCellularComponent | npBAF complex | 4.62e-04 | 14 | 48 | 2 | GO:0071564 | |
| GeneOntologyCellularComponent | GBAF complex | 4.62e-04 | 14 | 48 | 2 | GO:0140288 | |
| GeneOntologyCellularComponent | nBAF complex | 6.07e-04 | 16 | 48 | 2 | GO:0071565 | |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | 9.28e-04 | 899 | 48 | 8 | GO:0099513 | |
| GeneOntologyCellularComponent | supramolecular fiber | 1.28e-03 | 1179 | 48 | 9 | GO:0099512 | |
| GeneOntologyCellularComponent | supramolecular polymer | 1.34e-03 | 1187 | 48 | 9 | GO:0099081 | |
| GeneOntologyCellularComponent | SWI/SNF superfamily-type complex | 1.40e-03 | 96 | 48 | 3 | GO:0070603 | |
| GeneOntologyCellularComponent | heterochromatin | 1.62e-03 | 101 | 48 | 3 | GO:0000792 | |
| GeneOntologyCellularComponent | chromatin | 1.68e-03 | 1480 | 48 | 10 | GO:0000785 | |
| GeneOntologyCellularComponent | SWI/SNF complex | 2.16e-03 | 30 | 48 | 2 | GO:0016514 | |
| GeneOntologyCellularComponent | pericentric heterochromatin | 2.45e-03 | 32 | 48 | 2 | GO:0005721 | |
| GeneOntologyCellularComponent | ATPase complex | 3.24e-03 | 129 | 48 | 3 | GO:1904949 | |
| GeneOntologyCellularComponent | cytoplasmic microtubule | 3.53e-03 | 133 | 48 | 3 | GO:0005881 | |
| MousePheno | hyperactivity | TAS2R14 ILK TUBA1A BTBD7 ESR1 SMARCA2 TAAR1 CHD3 ADGRV1 TUBA8 ZZEF1 NR1D1 | 3.57e-06 | 1172 | 31 | 12 | MP:0001399 |
| Domain | Alpha_tubulin | 1.68e-17 | 9 | 48 | 7 | IPR002452 | |
| Domain | Tubulin/FtsZ_2-layer-sand-dom | 7.76e-14 | 22 | 48 | 7 | IPR018316 | |
| Domain | Tubulin_C | 7.76e-14 | 22 | 48 | 7 | SM00865 | |
| Domain | Tubulin_C | 7.76e-14 | 22 | 48 | 7 | PF03953 | |
| Domain | Tubulin_C | 1.11e-13 | 23 | 48 | 7 | IPR023123 | |
| Domain | TUBULIN | 1.11e-13 | 23 | 48 | 7 | PS00227 | |
| Domain | Tubulin | 1.11e-13 | 23 | 48 | 7 | IPR000217 | |
| Domain | Tub_FtsZ_C | 1.11e-13 | 23 | 48 | 7 | IPR008280 | |
| Domain | Tubulin | 1.11e-13 | 23 | 48 | 7 | SM00864 | |
| Domain | Tubulin_CS | 1.11e-13 | 23 | 48 | 7 | IPR017975 | |
| Domain | Tubulin_FtsZ_GTPase | 1.57e-13 | 24 | 48 | 7 | IPR003008 | |
| Domain | Tubulin | 1.57e-13 | 24 | 48 | 7 | PF00091 | |
| Domain | BRK | 5.42e-13 | 6 | 48 | 5 | SM00592 | |
| Domain | BRK_domain | 5.42e-13 | 6 | 48 | 5 | IPR006576 | |
| Domain | BRK | 5.42e-13 | 6 | 48 | 5 | PF07533 | |
| Domain | SNF2_N | 1.50e-12 | 32 | 48 | 7 | PF00176 | |
| Domain | SNF2_N | 1.50e-12 | 32 | 48 | 7 | IPR000330 | |
| Domain | - | 7.86e-12 | 20 | 48 | 6 | 3.30.1330.20 | |
| Domain | - | 1.10e-11 | 21 | 48 | 6 | 1.10.287.600 | |
| Domain | - | 1.51e-11 | 22 | 48 | 6 | 3.40.50.1440 | |
| Domain | Helicase_C | 1.01e-08 | 107 | 48 | 7 | PF00271 | |
| Domain | HELICc | 1.01e-08 | 107 | 48 | 7 | SM00490 | |
| Domain | Helicase_C | 1.08e-08 | 108 | 48 | 7 | IPR001650 | |
| Domain | HELICASE_CTER | 1.15e-08 | 109 | 48 | 7 | PS51194 | |
| Domain | HELICASE_ATP_BIND_1 | 1.15e-08 | 109 | 48 | 7 | PS51192 | |
| Domain | DEXDc | 1.15e-08 | 109 | 48 | 7 | SM00487 | |
| Domain | Helicase_ATP-bd | 1.22e-08 | 110 | 48 | 7 | IPR014001 | |
| Domain | Chromo_domain | 3.93e-07 | 24 | 48 | 4 | IPR023780 | |
| Domain | Chromo | 5.51e-07 | 26 | 48 | 4 | PF00385 | |
| Domain | CHROMO_2 | 7.51e-07 | 28 | 48 | 4 | PS50013 | |
| Domain | CHROMO_1 | 7.51e-07 | 28 | 48 | 4 | PS00598 | |
| Domain | Chromodomain-like | 1.31e-06 | 32 | 48 | 4 | IPR016197 | |
| Domain | CHROMO | 1.49e-06 | 33 | 48 | 4 | SM00298 | |
| Domain | Chromo/shadow_dom | 1.49e-06 | 33 | 48 | 4 | IPR000953 | |
| Domain | SnAC | 6.47e-06 | 2 | 48 | 2 | SM01314 | |
| Domain | QLQ | 6.47e-06 | 2 | 48 | 2 | PS51666 | |
| Domain | Gln-Leu-Gln_QLQ | 6.47e-06 | 2 | 48 | 2 | IPR014978 | |
| Domain | SnAC | 6.47e-06 | 2 | 48 | 2 | IPR029295 | |
| Domain | QLQ | 6.47e-06 | 2 | 48 | 2 | PF08880 | |
| Domain | SnAC | 6.47e-06 | 2 | 48 | 2 | PF14619 | |
| Domain | QLQ | 6.47e-06 | 2 | 48 | 2 | SM00951 | |
| Domain | HSA | 3.87e-05 | 4 | 48 | 2 | SM00573 | |
| Domain | HSA | 3.87e-05 | 4 | 48 | 2 | PS51204 | |
| Domain | HSA_dom | 3.87e-05 | 4 | 48 | 2 | IPR014012 | |
| Domain | HSA | 3.87e-05 | 4 | 48 | 2 | PF07529 | |
| Domain | GPCR_Rhodpsn_7TM | 4.46e-05 | 670 | 48 | 9 | IPR017452 | |
| Domain | 7tm_1 | 4.84e-05 | 677 | 48 | 9 | PF00001 | |
| Domain | G_PROTEIN_RECEP_F1_1 | 5.30e-05 | 685 | 48 | 9 | PS00237 | |
| Domain | G_PROTEIN_RECEP_F1_2 | 5.67e-05 | 691 | 48 | 9 | PS50262 | |
| Domain | GPCR_Rhodpsn | 5.73e-05 | 692 | 48 | 9 | IPR000276 | |
| Domain | Olfact_rcpt | 6.06e-05 | 393 | 48 | 7 | IPR000725 | |
| Domain | DNA/RNA_helicase_DEAH_CS | 9.84e-05 | 35 | 48 | 3 | IPR002464 | |
| Domain | DEAH_ATP_HELICASE | 1.26e-04 | 38 | 48 | 3 | PS00690 | |
| Domain | zf-C4 | 2.24e-04 | 46 | 48 | 3 | PF00105 | |
| Domain | NUCLEAR_REC_DBD_1 | 2.24e-04 | 46 | 48 | 3 | PS00031 | |
| Domain | Znf_hrmn_rcpt | 2.24e-04 | 46 | 48 | 3 | IPR001628 | |
| Domain | Nuclear_hrmn_rcpt | 2.24e-04 | 46 | 48 | 3 | IPR001723 | |
| Domain | ZnF_C4 | 2.24e-04 | 46 | 48 | 3 | SM00399 | |
| Domain | NUCLEAR_REC_DBD_2 | 2.24e-04 | 46 | 48 | 3 | PS51030 | |
| Domain | - | 2.39e-04 | 47 | 48 | 3 | 1.10.565.10 | |
| Domain | HOLI | 2.54e-04 | 48 | 48 | 3 | SM00430 | |
| Domain | Nucl_hrmn_rcpt_lig-bd | 2.54e-04 | 48 | 48 | 3 | IPR000536 | |
| Domain | Hormone_recep | 2.54e-04 | 48 | 48 | 3 | PF00104 | |
| Domain | - | 4.23e-04 | 57 | 48 | 3 | 3.30.50.10 | |
| Domain | Znf_NHR/GATA | 4.45e-04 | 58 | 48 | 3 | IPR013088 | |
| Domain | - | 5.71e-04 | 746 | 48 | 8 | 3.40.50.300 | |
| Domain | P-loop_NTPase | 1.31e-03 | 848 | 48 | 8 | IPR027417 | |
| Domain | Bromodomain_CS | 2.02e-03 | 26 | 48 | 2 | IPR018359 | |
| Domain | BROMODOMAIN_1 | 4.07e-03 | 37 | 48 | 2 | PS00633 | |
| Domain | Bromodomain | 4.29e-03 | 38 | 48 | 2 | PF00439 | |
| Domain | BROMODOMAIN_2 | 4.98e-03 | 41 | 48 | 2 | PS50014 | |
| Domain | BROMO | 5.22e-03 | 42 | 48 | 2 | SM00297 | |
| Domain | Bromodomain | 5.22e-03 | 42 | 48 | 2 | IPR001487 | |
| Domain | - | 5.22e-03 | 42 | 48 | 2 | 1.20.920.10 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_ESCHERICHIA_ESPG_TO_MICROTUBULE_RHOA_SIGNALING_PATHWAY | 4.76e-17 | 17 | 40 | 8 | M47768 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_DCTN1_TO_RETROGRADE_AXONAL_TRANSPORT | 8.54e-17 | 18 | 40 | 8 | M47753 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_IRON_TO_ANTEROGRADE_AXONAL_TRANSPORT | 1.47e-16 | 19 | 40 | 8 | M47818 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_ZN_TO_ANTEROGRADE_AXONAL_TRANSPORT | 1.47e-16 | 19 | 40 | 8 | M47813 | |
| Pathway | KEGG_MEDICUS_REFERENCE_KINETOCHORE_MICROTUBULE_ATTACHMENT | 2.45e-16 | 20 | 40 | 8 | M47890 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MICROTUBULE_DEPOLYMERIZATION_AT_THE_MINUS_ENDS | 2.45e-16 | 20 | 40 | 8 | M47911 | |
| Pathway | REACTOME_TRANSPORT_OF_CONNEXONS_TO_THE_PLASMA_MEMBRANE | 3.95e-16 | 21 | 40 | 8 | M27067 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MICROTUBULE_RHOA_SIGNALING_PATHWAY | 3.95e-16 | 21 | 40 | 8 | M47767 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PROMOTION_OF_MICROTUBULE_GROWTH | 6.19e-16 | 22 | 40 | 8 | M47903 | |
| Pathway | REACTOME_POST_CHAPERONIN_TUBULIN_FOLDING_PATHWAY | 9.48e-16 | 23 | 40 | 8 | M19135 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MICROTUBULE_DEPOLYMERIZATION | 9.48e-16 | 23 | 40 | 8 | M47910 | |
| Pathway | KEGG_MEDICUS_REFERENCE_KINETOCHORE_FIBER_ORGANIZATION | 9.48e-16 | 23 | 40 | 8 | M47900 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ANTEROGRADE_AXONAL_TRANSPORT | 1.42e-15 | 24 | 40 | 8 | M47671 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_ANTEROGRADE_AXONAL_TRANSPORT | 1.42e-15 | 24 | 40 | 8 | M47700 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_SALMONELLA_SIFA_TO_MICROTUBULE_PLUS_END_DIRECTED_TRANSPORT | 2.08e-15 | 25 | 40 | 8 | M47775 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SNCA_TO_ANTEROGRADE_AXONAL_TRANSPORT | 2.08e-15 | 25 | 40 | 8 | M47710 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_ANTEROGRADE_AXONAL_TRANSPORT | 3.00e-15 | 26 | 40 | 8 | M47672 | |
| Pathway | REACTOME_FORMATION_OF_TUBULIN_FOLDING_INTERMEDIATES_BY_CCT_TRIC | 3.00e-15 | 26 | 40 | 8 | M9648 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MICROTUBULE_NUCLEATION | 5.95e-15 | 28 | 40 | 8 | M47898 | |
| Pathway | REACTOME_ACTIVATION_OF_AMPK_DOWNSTREAM_OF_NMDARS | 8.20e-15 | 29 | 40 | 8 | M27948 | |
| Pathway | REACTOME_SEALING_OF_THE_NUCLEAR_ENVELOPE_NE_BY_ESCRT_III | 2.00e-14 | 32 | 40 | 8 | M29848 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_IQGAPS | 2.00e-14 | 32 | 40 | 8 | M27491 | |
| Pathway | REACTOME_COOPERATION_OF_PREFOLDIN_AND_TRIC_CCT_IN_ACTIN_AND_TUBULIN_FOLDING | 2.63e-14 | 33 | 40 | 8 | M27297 | |
| Pathway | KEGG_MEDICUS_REFERENCE_BRANCHING_MICROTUBULE_NUCLEATION | 2.63e-14 | 33 | 40 | 8 | M47901 | |
| Pathway | REACTOME_HSP90_CHAPERONE_CYCLE_FOR_STEROID_HORMONE_RECEPTORS_SHR_IN_THE_PRESENCE_OF_LIGAND | TUBA1B TUBA1A TUBA3D TUBA1C TUBA3E NR3C1 TUBA8 TUBA4A TUBA3C | 3.70e-14 | 57 | 40 | 9 | M27251 |
| Pathway | KEGG_MEDICUS_REFERENCE_ARL8_REGULATED_MICROTUBULE_PLUS_END_DIRECTED_TRANSPORT | 4.44e-14 | 35 | 40 | 8 | M47774 | |
| Pathway | REACTOME_GAP_JUNCTION_ASSEMBLY | 9.17e-14 | 38 | 40 | 8 | M14981 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RETROGRADE_AXONAL_TRANSPORT | 2.69e-13 | 43 | 40 | 8 | M47669 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RAB7_REGULATED_MICROTUBULE_MINUS_END_DIRECTED_TRANSPORT | 2.69e-13 | 43 | 40 | 8 | M47773 | |
| Pathway | REACTOME_AGGREPHAGY | 3.28e-13 | 44 | 40 | 8 | M29830 | |
| Pathway | REACTOME_ASSEMBLY_AND_CELL_SURFACE_PRESENTATION_OF_NMDA_RECEPTORS | 3.28e-13 | 44 | 40 | 8 | M27934 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_RETROGRADE_AXONAL_TRANSPORT | 3.98e-13 | 45 | 40 | 8 | M47670 | |
| Pathway | REACTOME_CARBOXYTERMINAL_POST_TRANSLATIONAL_MODIFICATIONS_OF_TUBULIN | 4.81e-13 | 46 | 40 | 8 | M27828 | |
| Pathway | REACTOME_RECYCLING_PATHWAY_OF_L1 | 8.27e-13 | 49 | 40 | 8 | M891 | |
| Pathway | REACTOME_GAP_JUNCTION_TRAFFICKING_AND_REGULATION | 1.16e-12 | 51 | 40 | 8 | M26972 | |
| Pathway | REACTOME_COPI_INDEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC | 1.61e-12 | 53 | 40 | 8 | M27651 | |
| Pathway | WP_PATHOGENIC_ESCHERICHIA_COLI_INFECTION | 2.21e-12 | 55 | 40 | 8 | M39613 | |
| Pathway | KEGG_PATHOGENIC_ESCHERICHIA_COLI_INFECTION | 2.57e-12 | 56 | 40 | 8 | M2333 | |
| Pathway | REACTOME_TRANSPORT_OF_CONNEXONS_TO_THE_PLASMA_MEMBRANE | 4.26e-12 | 17 | 40 | 6 | MM14731 | |
| Pathway | REACTOME_KINESINS | 5.27e-12 | 61 | 40 | 8 | M977 | |
| Pathway | BIOCARTA_MTA3_PATHWAY | 1.33e-11 | 20 | 40 | 6 | MM1383 | |
| Pathway | WP_PARKINUBIQUITIN_PROTEASOMAL_SYSTEM_PATHWAY | 1.87e-11 | 71 | 40 | 8 | M39690 | |
| Pathway | REACTOME_TRANSLOCATION_OF_SLC2A4_GLUT4_TO_THE_PLASMA_MEMBRANE | 2.09e-11 | 72 | 40 | 8 | M26954 | |
| Pathway | REACTOME_NUCLEAR_ENVELOPE_NE_REASSEMBLY | 3.27e-11 | 76 | 40 | 8 | M27215 | |
| Pathway | REACTOME_PKR_MEDIATED_SIGNALING | 3.27e-11 | 76 | 40 | 8 | M48037 | |
| Pathway | REACTOME_THE_ROLE_OF_GTSE1_IN_G2_M_PROGRESSION_AFTER_G2_CHECKPOINT | 4.50e-11 | 79 | 40 | 8 | M27743 | |
| Pathway | REACTOME_CARBOXYTERMINAL_POST_TRANSLATIONAL_MODIFICATIONS_OF_TUBULIN | 9.99e-11 | 27 | 40 | 6 | MM15549 | |
| Pathway | REACTOME_SEALING_OF_THE_NUCLEAR_ENVELOPE_NE_BY_ESCRT_III | 9.99e-11 | 27 | 40 | 6 | MM15674 | |
| Pathway | REACTOME_HSP90_CHAPERONE_CYCLE_FOR_STEROID_HORMONE_RECEPTORS_SHR_IN_THE_PRESENCE_OF_LIGAND | 1.04e-10 | 52 | 40 | 7 | MM14949 | |
| Pathway | REACTOME_SELECTIVE_AUTOPHAGY | 1.31e-10 | 90 | 40 | 8 | M29841 | |
| Pathway | KEGG_GAP_JUNCTION | 1.31e-10 | 90 | 40 | 8 | M4013 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_IQGAPS | 1.60e-10 | 29 | 40 | 6 | MM15219 | |
| Pathway | REACTOME_ACTIVATION_OF_NMDA_RECEPTORS_AND_POSTSYNAPTIC_EVENTS | 1.86e-10 | 94 | 40 | 8 | M2843 | |
| Pathway | REACTOME_RECRUITMENT_OF_NUMA_TO_MITOTIC_CENTROSOMES | 2.03e-10 | 95 | 40 | 8 | M6729 | |
| Pathway | REACTOME_PROTEIN_FOLDING | 2.61e-10 | 98 | 40 | 8 | M776 | |
| Pathway | REACTOME_GAP_JUNCTION_ASSEMBLY | 3.03e-10 | 32 | 40 | 6 | MM14730 | |
| Pathway | REACTOME_COPI_DEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC | 3.08e-10 | 100 | 40 | 8 | M27650 | |
| Pathway | REACTOME_COPI_MEDIATED_ANTEROGRADE_TRANSPORT | 3.61e-10 | 102 | 40 | 8 | M27648 | |
| Pathway | REACTOME_AGGREPHAGY | 6.45e-10 | 36 | 40 | 6 | MM15669 | |
| Pathway | REACTOME_RECYCLING_PATHWAY_OF_L1 | 7.69e-10 | 37 | 40 | 6 | MM15102 | |
| Pathway | REACTOME_L1CAM_INTERACTIONS | 1.43e-09 | 121 | 40 | 8 | M872 | |
| Pathway | REACTOME_MHC_CLASS_II_ANTIGEN_PRESENTATION | 1.97e-09 | 126 | 40 | 8 | M705 | |
| Pathway | REACTOME_RESOLUTION_OF_SISTER_CHROMATID_COHESION | 2.10e-09 | 127 | 40 | 8 | M27181 | |
| Pathway | REACTOME_GAP_JUNCTION_TRAFFICKING_AND_REGULATION | 2.30e-09 | 44 | 40 | 6 | MM14606 | |
| Pathway | REACTOME_GOLGI_TO_ER_RETROGRADE_TRANSPORT | 3.22e-09 | 134 | 40 | 8 | M27751 | |
| Pathway | REACTOME_COPI_INDEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC | 3.97e-09 | 48 | 40 | 6 | MM15353 | |
| Pathway | REACTOME_HCMV_EARLY_EVENTS | 4.06e-09 | 138 | 40 | 8 | M29805 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_FORMINS | 4.55e-09 | 140 | 40 | 8 | M27550 | |
| Pathway | REACTOME_ORGANELLE_BIOGENESIS_AND_MAINTENANCE | TUBA1B TUBA1A TUBA3D TUBA1C TUBA3E CHD9 TUBA8 NR1D1 TUBA4A TUBA3C | 7.18e-09 | 297 | 40 | 10 | M27050 |
| Pathway | REACTOME_INTRAFLAGELLAR_TRANSPORT | 8.24e-09 | 54 | 40 | 6 | M27482 | |
| Pathway | REACTOME_ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES | 8.28e-09 | 151 | 40 | 8 | M550 | |
| Pathway | REACTOME_ER_TO_GOLGI_ANTEROGRADE_TRANSPORT | 1.07e-08 | 156 | 40 | 8 | M27097 | |
| Pathway | REACTOME_KINESINS | 1.15e-08 | 57 | 40 | 6 | MM15714 | |
| Pathway | REACTOME_AUTOPHAGY | 1.18e-08 | 158 | 40 | 8 | M27935 | |
| Pathway | REACTOME_HCMV_INFECTION | 1.44e-08 | 162 | 40 | 8 | M29804 | |
| Pathway | REACTOME_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION | 2.10e-08 | 170 | 40 | 8 | M941 | |
| Pathway | REACTOME_PKR_MEDIATED_SIGNALING | 2.83e-08 | 66 | 40 | 6 | MM17074 | |
| Pathway | REACTOME_NUCLEAR_ENVELOPE_NE_REASSEMBLY | 3.39e-08 | 68 | 40 | 6 | MM14921 | |
| Pathway | REACTOME_L1CAM_INTERACTIONS | 3.39e-08 | 68 | 40 | 6 | MM14968 | |
| Pathway | REACTOME_TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION | 4.42e-08 | 187 | 40 | 8 | M961 | |
| Pathway | REACTOME_SEPARATION_OF_SISTER_CHROMATIDS | 5.20e-08 | 191 | 40 | 8 | M29614 | |
| Pathway | REACTOME_THE_ROLE_OF_GTSE1_IN_G2_M_PROGRESSION_AFTER_G2_CHECKPOINT | 5.22e-08 | 73 | 40 | 6 | MM15491 | |
| Pathway | REACTOME_SELECTIVE_AUTOPHAGY | 5.22e-08 | 73 | 40 | 6 | MM15672 | |
| Pathway | REACTOME_MITOTIC_G2_G2_M_PHASES | 7.44e-08 | 200 | 40 | 8 | M864 | |
| Pathway | REACTOME_CILIUM_ASSEMBLY | 7.73e-08 | 201 | 40 | 8 | M27472 | |
| Pathway | REACTOME_INTRA_GOLGI_AND_RETROGRADE_GOLGI_TO_ER_TRAFFIC | 8.34e-08 | 203 | 40 | 8 | M27654 | |
| Pathway | REACTOME_MITOTIC_PROMETAPHASE | 8.67e-08 | 204 | 40 | 8 | M4217 | |
| Pathway | REACTOME_NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION | 9.00e-08 | 205 | 40 | 8 | M752 | |
| Pathway | BIOCARTA_MTA3_PATHWAY | 1.65e-07 | 18 | 40 | 4 | M225 | |
| Pathway | REACTOME_RECRUITMENT_OF_NUMA_TO_MITOTIC_CENTROSOMES | 1.84e-07 | 90 | 40 | 6 | MM14979 | |
| Pathway | REACTOME_RHO_GTPASE_EFFECTORS | TUBA1B TUBA1A KDM4C TUBA3D TUBA1C TUBA3E TUBA8 TUBA4A TUBA3C | 2.28e-07 | 323 | 40 | 9 | M27080 |
| Pathway | REACTOME_ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES | 2.39e-07 | 94 | 40 | 6 | MM14515 | |
| Pathway | REACTOME_MITOTIC_METAPHASE_AND_ANAPHASE | 2.65e-07 | 236 | 40 | 8 | M27185 | |
| Pathway | REACTOME_COPI_DEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC | 3.07e-07 | 98 | 40 | 6 | MM15352 | |
| Pathway | REACTOME_INTRAFLAGELLAR_TRANSPORT | 3.35e-07 | 52 | 40 | 5 | MM15211 | |
| Pathway | WP_ALZHEIMERS_DISEASE | 5.71e-07 | 261 | 40 | 8 | M42565 | |
| Pathway | REACTOME_COPI_MEDIATED_ANTEROGRADE_TRANSPORT | 6.09e-07 | 110 | 40 | 6 | MM15350 | |
| Pathway | REACTOME_HEDGEHOG_OFF_STATE | 7.14e-07 | 113 | 40 | 6 | M27471 | |
| Pathway | REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES | 7.38e-07 | 270 | 40 | 8 | M15514 | |
| Pathway | REACTOME_INTERFERON_SIGNALING | 8.02e-07 | 273 | 40 | 8 | M983 | |
| Pubmed | 7.64e-23 | 9 | 49 | 8 | 21167302 | ||
| Pubmed | 6.35e-19 | 19 | 49 | 8 | 15691386 | ||
| Pubmed | 6.35e-19 | 19 | 49 | 8 | 15698476 | ||
| Pubmed | 2.68e-18 | 22 | 49 | 8 | 28117675 | ||
| Pubmed | Histone deacetylase 6 regulates human immunodeficiency virus type 1 infection. | 1.59e-16 | 8 | 49 | 6 | 16148047 | |
| Pubmed | Systematic Analysis of the Functions of Lysine Acetylation in the Regulation of Tat Activity. | 1.18e-15 | 22 | 49 | 7 | 23826228 | |
| Pubmed | The glutamine-rich region of the HIV-1 Tat protein is involved in T-cell apoptosis. | 5.23e-15 | 12 | 49 | 6 | 15331610 | |
| Pubmed | HIV-1 rev depolymerizes microtubules to form stable bilayered rings. | 9.69e-15 | 13 | 49 | 6 | 10908577 | |
| Pubmed | 1.69e-14 | 14 | 49 | 6 | 12486001 | ||
| Pubmed | The N-terminal domain of c-Myc associates with alpha-tubulin and microtubules in vivo and in vitro. | 2.70e-14 | 6 | 49 | 5 | 7651436 | |
| Pubmed | 2.70e-14 | 6 | 49 | 5 | 16327313 | ||
| Pubmed | 2.70e-14 | 6 | 49 | 5 | 3785200 | ||
| Pubmed | 9.43e-14 | 7 | 49 | 5 | 11146551 | ||
| Pubmed | 4.18e-13 | 22 | 49 | 6 | 15103018 | ||
| Pubmed | Interaction between metabotropic glutamate receptor 7 and alpha tubulin. | 5.64e-13 | 9 | 49 | 5 | 11953448 | |
| Pubmed | 3.48e-12 | 4 | 49 | 4 | 18400243 | ||
| Pubmed | 2.75e-11 | 17 | 49 | 5 | 17360745 | ||
| Pubmed | 1.21e-10 | 7 | 49 | 4 | 36681692 | ||
| Pubmed | Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing. | 1.45e-10 | 271 | 49 | 9 | 32433965 | |
| Pubmed | 6.08e-10 | 212 | 49 | 8 | 23463506 | ||
| Pubmed | 2.63e-09 | 3 | 49 | 3 | 11121746 | ||
| Pubmed | Tubulin and FtsZ structures: functional and therapeutic implications. | 2.63e-09 | 3 | 49 | 3 | 9722999 | |
| Pubmed | 2.63e-09 | 3 | 49 | 3 | 11163133 | ||
| Pubmed | Ligand-dependent interaction between the estrogen receptor and the human homologues of SWI2/SNF2. | 2.63e-09 | 3 | 49 | 3 | 9099865 | |
| Pubmed | 4.22e-09 | 94 | 49 | 6 | 36584595 | ||
| Pubmed | 5.72e-09 | 282 | 49 | 8 | 23667531 | ||
| Pubmed | Altered control of cellular proliferation in the absence of mammalian brahma (SNF2alpha). | 2.62e-08 | 5 | 49 | 3 | 9843504 | |
| Pubmed | 4.45e-08 | 239 | 49 | 7 | 23246001 | ||
| Pubmed | 5.24e-08 | 6 | 49 | 3 | 10840040 | ||
| Pubmed | Analysis of estrogen receptor alpha signaling complex at the plasma membrane. | 5.24e-08 | 6 | 49 | 3 | 15556606 | |
| Pubmed | 5.24e-08 | 6 | 49 | 3 | 18613978 | ||
| Pubmed | 5.24e-08 | 6 | 49 | 3 | 12090300 | ||
| Pubmed | 9.16e-08 | 157 | 49 | 6 | 30186101 | ||
| Pubmed | 9.16e-08 | 7 | 49 | 3 | 17043312 | ||
| Pubmed | 9.16e-08 | 7 | 49 | 3 | 21445275 | ||
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | 1.10e-07 | 582 | 49 | 9 | 20467437 | |
| Pubmed | CCT3 acts upstream of YAP and TFCP2 as a potential target and tumour biomarker in liver cancer. | 1.58e-07 | 288 | 49 | 7 | 31501420 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | 1.58e-07 | 608 | 49 | 9 | 36089195 | |
| Pubmed | 2.19e-07 | 9 | 49 | 3 | 19103752 | ||
| Pubmed | Proteomic dissection of the von Hippel-Lindau (VHL) interactome. | 2.77e-07 | 98 | 49 | 5 | 21942715 | |
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | 4.13e-07 | 332 | 49 | 7 | 32786267 | |
| Pubmed | Ikaros DNA-binding proteins direct formation of chromatin remodeling complexes in lymphocytes. | 4.30e-07 | 11 | 49 | 3 | 10204490 | |
| Pubmed | 4.30e-07 | 11 | 49 | 3 | 12917342 | ||
| Pubmed | Dysferlin interacts with tubulin and microtubules in mouse skeletal muscle. | 4.30e-07 | 11 | 49 | 3 | 20405035 | |
| Pubmed | TUBA1B TUBA1A LIN28B TUBA1C TUBA3E CHD9 CHD8 CHD3 CHD6 TUBA8 TUBA4A | 4.65e-07 | 1153 | 49 | 11 | 29845934 | |
| Pubmed | 7.44e-07 | 13 | 49 | 3 | 14697242 | ||
| Pubmed | Bmx is a downstream Rap1 effector in VEGF-induced endothelial cell activation. | 7.44e-07 | 13 | 49 | 3 | 15207703 | |
| Pubmed | 7.63e-07 | 50 | 49 | 4 | 23703321 | ||
| Pubmed | Quantitative interactome proteomics identifies a proteostasis network for GABAA receptors. | 9.30e-07 | 125 | 49 | 5 | 36030824 | |
| Pubmed | 1.18e-06 | 15 | 49 | 3 | 14701856 | ||
| Pubmed | TUBA1B ZBTB38 KDM4C SMARCA4 CHD9 CCN2 CHD6 ZNF841 NR1D1 ZMYM5 ZNF292 | 1.34e-06 | 1285 | 49 | 11 | 35914814 | |
| Pubmed | The gluconeogenic enzyme PCK1 phosphorylates INSIG1/2 for lipogenesis. | 1.68e-06 | 141 | 49 | 5 | 32322062 | |
| Pubmed | 1.69e-06 | 808 | 49 | 9 | 20412781 | ||
| Pubmed | Structural features and restricted expression of a human alpha-tubulin gene. | 1.94e-06 | 2 | 49 | 2 | 3839072 | |
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 8670841 | ||
| Pubmed | Chromatin remodeling during glucocorticoid receptor regulated transactivation. | 1.94e-06 | 2 | 49 | 2 | 22425674 | |
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 17951996 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 23163725 | ||
| Pubmed | Combined gene dosage requirement for SWI/SNF catalytic subunits during early mammalian development. | 1.94e-06 | 2 | 49 | 2 | 23076393 | |
| Pubmed | Differential preimplantation regulation of two mouse homologues of the yeast SWI2 protein. | 1.94e-06 | 2 | 49 | 2 | 9603422 | |
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 16523501 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 15576411 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 23803465 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 23276717 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 27097303 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 15240517 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 21646426 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 26564006 | ||
| Pubmed | SMARCA4/SMARCA2-deficient Carcinoma of the Esophagus and Gastroesophageal Junction. | 1.94e-06 | 2 | 49 | 2 | 33027072 | |
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 28038711 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 8223438 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 23872584 | ||
| Pubmed | Proinflammatory stimuli engage Brahma related gene 1 and Brahma in endothelial injury. | 1.94e-06 | 2 | 49 | 2 | 23963727 | |
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 12493776 | ||
| Pubmed | Aldosterone induces CTGF in mesangial cells by activation of the glucocorticoid receptor. | 1.94e-06 | 2 | 49 | 2 | 17602195 | |
| Pubmed | Heterozygous Mutations in SMARCA2 Reprogram the Enhancer Landscape by Global Retargeting of SMARCA4. | 1.94e-06 | 2 | 49 | 2 | 31375262 | |
| Pubmed | Alterations of the SWI/SNF chromatin remodelling subunit-BRG1 and BRM in hepatocellular carcinoma. | 1.94e-06 | 2 | 49 | 2 | 23088494 | |
| Pubmed | Acetylated α-tubulin is reduced in individuals with poor sperm motility. | 1.94e-06 | 2 | 49 | 2 | 24268707 | |
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 17075831 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 20333683 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 34812766 | ||
| Pubmed | CHD6 is a DNA-dependent ATPase and localizes at nuclear sites of mRNA synthesis. | 1.94e-06 | 2 | 49 | 2 | 17027977 | |
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 15576061 | ||
| Pubmed | Loss of SWI/SNF Chromatin Remodeling Alters NRF2 Signaling in Non-Small Cell Lung Carcinoma. | 1.94e-06 | 2 | 49 | 2 | 32855269 | |
| Pubmed | Targeting of BRM Sensitizes BRG1-Mutant Lung Cancer Cell Lines to Radiotherapy. | 1.94e-06 | 2 | 49 | 2 | 30478150 | |
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 25580742 | ||
| Pubmed | Downregulation of SWI/SNF chromatin remodeling factor subunits modulates cisplatin cytotoxicity. | 1.94e-06 | 2 | 49 | 2 | 22721696 | |
| Pubmed | Role of ERK1/2 and PI3-K in the regulation of CTGF-induced ILK expression in HK-2 cells. | 1.94e-06 | 2 | 49 | 2 | 17498677 | |
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 18508913 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 11719516 | ||
| Pubmed | Proliferation-associated SNF2-like gene (PASG): a SNF2 family member altered in leukemia. | 1.94e-06 | 2 | 49 | 2 | 10910076 | |
| Pubmed | The SWI/SNF ATPases Are Required for Triple Negative Breast Cancer Cell Proliferation. | 1.94e-06 | 2 | 49 | 2 | 25808524 | |
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 21913214 | ||
| Pubmed | Interaction of the glucocorticoid receptor with the chromatin landscape. | 1.94e-06 | 2 | 49 | 2 | 18342607 | |
| Pubmed | A novel putative helicase produced in early murine lymphocytes. | 1.94e-06 | 2 | 49 | 2 | 8647447 | |
| Pubmed | Antagonistic roles for BRM and BRG1 SWI/SNF complexes in differentiation. | 1.94e-06 | 2 | 49 | 2 | 19144648 | |
| Pubmed | DNA binding drives the association of BRG1/hBRM bromodomains with nucleosomes. | 1.94e-06 | 2 | 49 | 2 | 28706277 | |
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 29514097 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 21092585 | ||
| Pubmed | High expression of SMARCA4 or SMARCA2 is frequently associated with an opposite prognosis in cancer. | 1.94e-06 | 2 | 49 | 2 | 29391527 | |
| Interaction | TCP11L2 interactions | 2.27e-14 | 21 | 46 | 7 | int:TCP11L2 | |
| Interaction | GRM7 interactions | 5.62e-10 | 19 | 46 | 5 | int:GRM7 | |
| Interaction | TTC5 interactions | 7.53e-09 | 65 | 46 | 6 | int:TTC5 | |
| Interaction | ZC2HC1A interactions | 3.41e-07 | 64 | 46 | 5 | int:ZC2HC1A | |
| Interaction | TXNDC9 interactions | 3.68e-07 | 124 | 46 | 6 | int:TXNDC9 | |
| Interaction | CD81 interactions | 3.78e-07 | 303 | 46 | 8 | int:CD81 | |
| Interaction | LTA interactions | 4.67e-07 | 28 | 46 | 4 | int:LTA | |
| Interaction | ADARB1 interactions | 1.34e-06 | 489 | 46 | 9 | int:ADARB1 | |
| Interaction | PBRM1 interactions | 1.82e-06 | 258 | 46 | 7 | int:PBRM1 | |
| Interaction | DPF3 interactions | 2.46e-06 | 95 | 46 | 5 | int:DPF3 | |
| Interaction | TRIM28 interactions | TUBA1B ELOA ILK TUBA1A LIN28B ESR1 SMARCA2 SMARCA4 CHD3 ZNF841 NR3C1 TUBA4A ZNF669 ZNF77 | 3.05e-06 | 1474 | 46 | 14 | int:TRIM28 |
| Interaction | TUBB4B interactions | TUBA1B TUBA1A TUBA3D TUBA1C SMARCA4 CHD3 NR3C1 TUBA4A TUBA3C | 4.08e-06 | 560 | 46 | 9 | int:TUBB4B |
| Interaction | H3C1 interactions | ELOA KDM4C ESR1 SMARCA2 SMARCA4 CHD8 CHD3 NR3C1 ZZEF1 ZNF292 HELLS | 4.25e-06 | 901 | 46 | 11 | int:H3C1 |
| Interaction | YAP1 interactions | TUBA1B TUBA1A TUBA1C SMARCA2 SMARCA4 TUBA3E CHD8 TUBA8 NR1D1 TUBA4A TUBA3C CNOT4 | 4.35e-06 | 1095 | 46 | 12 | int:YAP1 |
| Interaction | CAPSL interactions | 4.97e-06 | 15 | 46 | 3 | int:CAPSL | |
| Interaction | PHF12 interactions | 5.07e-06 | 110 | 46 | 5 | int:PHF12 | |
| Interaction | LARP7 interactions | TUBA1B TUBA1A LIN28B ESR1 TUBA1C TUBA3E CHD9 CHD8 CHD6 NR3C1 TUBA8 TUBA4A | 5.14e-06 | 1113 | 46 | 12 | int:LARP7 |
| Interaction | TFCP2 interactions | 5.71e-06 | 436 | 46 | 8 | int:TFCP2 | |
| Interaction | H3-3A interactions | 5.74e-06 | 749 | 46 | 10 | int:H3-3A | |
| Interaction | ADNP interactions | 5.80e-06 | 199 | 46 | 6 | int:ADNP | |
| Interaction | HDAC3 interactions | 6.49e-06 | 313 | 46 | 7 | int:HDAC3 | |
| Interaction | NSD3 interactions | 6.86e-06 | 117 | 46 | 5 | int:NSD3 | |
| Interaction | C4orf17 interactions | 7.40e-06 | 17 | 46 | 3 | int:C4orf17 | |
| Interaction | NR4A1 interactions | 8.33e-06 | 212 | 46 | 6 | int:NR4A1 | |
| Interaction | BSG interactions | TUBA1B TUBA1A TUBA3D TUBA1C TUBA3E NR3C1 TUBA8 TUBA4A TUBA3C | 1.07e-05 | 631 | 46 | 9 | int:BSG |
| Interaction | ERCC6 interactions | 1.14e-05 | 224 | 46 | 6 | int:ERCC6 | |
| Interaction | SOX2 interactions | TUBA1B ELOA ILK TUBA1A SMARCA2 SMARCA4 CHD9 CHD8 CCN2 CHD3 CHD6 TUBA4A ZNF292 | 1.15e-05 | 1422 | 46 | 13 | int:SOX2 |
| Interaction | CBX3 interactions | 1.29e-05 | 646 | 46 | 9 | int:CBX3 | |
| Interaction | PAK1 interactions | 1.29e-05 | 229 | 46 | 6 | int:PAK1 | |
| Interaction | UBL4A interactions | 1.32e-05 | 349 | 46 | 7 | int:UBL4A | |
| Interaction | KDM4A interactions | 1.37e-05 | 64 | 46 | 4 | int:KDM4A | |
| Interaction | KPNA1 interactions | 1.37e-05 | 351 | 46 | 7 | int:KPNA1 | |
| Interaction | BRD3 interactions | 1.42e-05 | 494 | 46 | 8 | int:BRD3 | |
| Interaction | H3C3 interactions | 1.44e-05 | 495 | 46 | 8 | int:H3C3 | |
| Interaction | RBBP7 interactions | 1.71e-05 | 507 | 46 | 8 | int:RBBP7 | |
| Interaction | TUBB6 interactions | 1.81e-05 | 243 | 46 | 6 | int:TUBB6 | |
| Interaction | BAGE2 interactions | 1.95e-05 | 70 | 46 | 4 | int:BAGE2 | |
| Interaction | KPNA3 interactions | 2.03e-05 | 248 | 46 | 6 | int:KPNA3 | |
| Interaction | CHD6 interactions | 2.06e-05 | 71 | 46 | 4 | int:CHD6 | |
| Interaction | GABRA1 interactions | 2.44e-05 | 152 | 46 | 5 | int:GABRA1 | |
| Interaction | BRINP3 interactions | 2.47e-05 | 25 | 46 | 3 | int:BRINP3 | |
| Interaction | CAPS interactions | 2.47e-05 | 25 | 46 | 3 | int:CAPS | |
| Interaction | IFNE interactions | 3.13e-05 | 27 | 46 | 3 | int:IFNE | |
| Interaction | COIL interactions | 3.14e-05 | 552 | 46 | 8 | int:COIL | |
| Interaction | PHF6 interactions | 3.31e-05 | 162 | 46 | 5 | int:PHF6 | |
| Interaction | ZC2HC1B interactions | 3.50e-05 | 28 | 46 | 3 | int:ZC2HC1B | |
| Interaction | VHL interactions | 3.52e-05 | 561 | 46 | 8 | int:VHL | |
| Interaction | SMC3 interactions | 3.59e-05 | 408 | 46 | 7 | int:SMC3 | |
| Interaction | BACE2 interactions | 3.65e-05 | 82 | 46 | 4 | int:BACE2 | |
| Interaction | PTEN interactions | TUBA1B TUBA1A ESR1 TUBA1C SMARCA4 CCN2 NR3C1 TUBA3C CNOT4 HELLS | 3.70e-05 | 929 | 46 | 10 | int:PTEN |
| Interaction | ATAD5 interactions | 4.01e-05 | 84 | 46 | 4 | int:ATAD5 | |
| Interaction | PFDN6 interactions | 4.06e-05 | 169 | 46 | 5 | int:PFDN6 | |
| Interaction | RUVBL1 interactions | 4.19e-05 | 575 | 46 | 8 | int:RUVBL1 | |
| Interaction | H2BC8 interactions | 4.25e-05 | 576 | 46 | 8 | int:H2BC8 | |
| Interaction | CDX2 interactions | 4.40e-05 | 86 | 46 | 4 | int:CDX2 | |
| Interaction | RBBP5 interactions | 4.59e-05 | 287 | 46 | 6 | int:RBBP5 | |
| Interaction | POU5F1 interactions | 4.68e-05 | 584 | 46 | 8 | int:POU5F1 | |
| Interaction | CBX1 interactions | 4.68e-05 | 288 | 46 | 6 | int:CBX1 | |
| Interaction | INSIG2 interactions | 5.06e-05 | 177 | 46 | 5 | int:INSIG2 | |
| Interaction | SUMO2 interactions | 5.09e-05 | 591 | 46 | 8 | int:SUMO2 | |
| Interaction | CCT3 interactions | 5.93e-05 | 604 | 46 | 8 | int:CCT3 | |
| Interaction | S100A8 interactions | 6.08e-05 | 184 | 46 | 5 | int:S100A8 | |
| Interaction | ZNF330 interactions | 6.30e-05 | 446 | 46 | 7 | int:ZNF330 | |
| Interaction | ARRB1 interactions | 6.32e-05 | 304 | 46 | 6 | int:ARRB1 | |
| Interaction | SERBP1 interactions | TUBA1B ELOA RANBP1 TUBA1A ESR1 TUBA1C TUBA3E CHD3 NR3C1 TUBA4A TUBA3C ZNF292 | 6.37e-05 | 1432 | 46 | 12 | int:SERBP1 |
| Interaction | THRB interactions | 6.40e-05 | 186 | 46 | 5 | int:THRB | |
| Interaction | TNPO1 interactions | 6.56e-05 | 306 | 46 | 6 | int:TNPO1 | |
| Interaction | NUP43 interactions | 7.54e-05 | 625 | 46 | 8 | int:NUP43 | |
| Interaction | KLK11 interactions | 7.54e-05 | 36 | 46 | 3 | int:KLK11 | |
| Interaction | LRP1 interactions | 8.20e-05 | 196 | 46 | 5 | int:LRP1 | |
| Interaction | CEBPA interactions | RANBP1 ILK ESR1 SMARCA2 SMARCA4 CHD9 CHD8 CHD3 NR3C1 ZNF292 HELLS | 8.59e-05 | 1245 | 46 | 11 | int:CEBPA |
| Interaction | NACC1 interactions | 8.90e-05 | 103 | 46 | 4 | int:NACC1 | |
| Interaction | LOXL4 interactions | 9.24e-05 | 104 | 46 | 4 | int:LOXL4 | |
| Interaction | INSYN2A interactions | 9.60e-05 | 39 | 46 | 3 | int:INSYN2A | |
| Interaction | CD48 interactions | 9.60e-05 | 39 | 46 | 3 | int:CD48 | |
| Interaction | TUBA1C interactions | 9.71e-05 | 478 | 46 | 7 | int:TUBA1C | |
| Interaction | CBX4 interactions | 1.01e-04 | 205 | 46 | 5 | int:CBX4 | |
| Interaction | TUBB2B interactions | 1.01e-04 | 205 | 46 | 5 | int:TUBB2B | |
| Interaction | APEX1 interactions | TUBA1B ELOA TAS2R14 ILK KDM4C ESR1 SMARCA4 CHD9 ZNF841 ZNF292 HELLS | 1.03e-04 | 1271 | 46 | 11 | int:APEX1 |
| Interaction | TBL1Y interactions | 1.04e-04 | 40 | 46 | 3 | int:TBL1Y | |
| Interaction | KLK5 interactions | 1.11e-04 | 109 | 46 | 4 | int:KLK5 | |
| Interaction | POLR1G interactions | 1.12e-04 | 489 | 46 | 7 | int:POLR1G | |
| Interaction | CDC5L interactions | 1.14e-04 | 855 | 46 | 9 | int:CDC5L | |
| Interaction | CCT2 interactions | 1.17e-04 | 666 | 46 | 8 | int:CCT2 | |
| Interaction | NUP210P1 interactions | 1.20e-04 | 42 | 46 | 3 | int:NUP210P1 | |
| Interaction | TUBA1B interactions | 1.25e-04 | 498 | 46 | 7 | int:TUBA1B | |
| Interaction | DPF2 interactions | 1.35e-04 | 349 | 46 | 6 | int:DPF2 | |
| Interaction | POLR1E interactions | 1.37e-04 | 350 | 46 | 6 | int:POLR1E | |
| Interaction | DNASE2B interactions | 1.38e-04 | 44 | 46 | 3 | int:DNASE2B | |
| Interaction | BRD9 interactions | 1.46e-04 | 117 | 46 | 4 | int:BRD9 | |
| Interaction | SIAH1 interactions | 1.50e-04 | 223 | 46 | 5 | int:SIAH1 | |
| Interaction | STAG2 interactions | 1.53e-04 | 224 | 46 | 5 | int:STAG2 | |
| Interaction | SKIL interactions | 1.56e-04 | 119 | 46 | 4 | int:SKIL | |
| Interaction | PTH2R interactions | 1.56e-04 | 119 | 46 | 4 | int:PTH2R | |
| Interaction | ITGAD interactions | 1.58e-04 | 46 | 46 | 3 | int:ITGAD | |
| Interaction | PRSS50 interactions | 1.58e-04 | 46 | 46 | 3 | int:PRSS50 | |
| Interaction | SSR2 interactions | 1.58e-04 | 46 | 46 | 3 | int:SSR2 | |
| Interaction | SHC1 interactions | 1.65e-04 | 362 | 46 | 6 | int:SHC1 | |
| Interaction | CENPV interactions | 1.66e-04 | 121 | 46 | 4 | int:CENPV | |
| Interaction | VAV1 interactions | 1.67e-04 | 228 | 46 | 5 | int:VAV1 | |
| Cytoband | 12q13.12 | 9.39e-06 | 38 | 49 | 3 | 12q13.12 | |
| Cytoband | 3q11.2 | 3.57e-04 | 26 | 49 | 2 | 3q11.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr11q11 | 8.48e-04 | 40 | 49 | 2 | chr11q11 | |
| Cytoband | 3q23 | 1.03e-03 | 44 | 49 | 2 | 3q23 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr12q13 | 1.09e-03 | 423 | 49 | 4 | chr12q13 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr3q11 | 1.54e-03 | 54 | 49 | 2 | chr3q11 | |
| Cytoband | 2q21.1 | 1.78e-03 | 58 | 49 | 2 | 2q21.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr3q23 | 2.09e-03 | 63 | 49 | 2 | chr3q23 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr16q12 | 5.47e-03 | 103 | 49 | 2 | chr16q12 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr9p24 | 5.68e-03 | 105 | 49 | 2 | chr9p24 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr6q23 | 7.24e-03 | 119 | 49 | 2 | chr6q23 | |
| GeneFamily | Tubulins | 4.13e-16 | 26 | 40 | 8 | 778 | |
| GeneFamily | Nuclear hormone receptors | 1.72e-04 | 49 | 40 | 3 | 71 | |
| GeneFamily | Olfactory receptors, family 4 | 2.89e-03 | 129 | 40 | 3 | 151 | |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_DN | 2.46e-06 | 54 | 46 | 4 | M1349 | |
| Coexpression | TOMIDA_METASTASIS_UP | 1.28e-05 | 26 | 46 | 3 | M17830 | |
| Coexpression | MODY_HIPPOCAMPUS_NEONATAL | 2.66e-05 | 33 | 46 | 3 | M7409 | |
| Coexpression | ALONSO_METASTASIS_EMT_UP | 3.18e-05 | 35 | 46 | 3 | M8191 | |
| Coexpression | GRYDER_PAX3FOXO1_ENHANCERS_IN_TADS | 5.47e-05 | 1009 | 46 | 9 | M157 | |
| Coexpression | ODONNELL_TARGETS_OF_MYC_AND_TFRC_DN | 7.28e-05 | 46 | 46 | 3 | M6792 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | 1.09e-04 | 856 | 46 | 8 | M4500 | |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_DN | 1.31e-04 | 56 | 46 | 3 | MM564 | |
| Coexpression | HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP | 1.51e-04 | 153 | 46 | 4 | M5588 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | 1.57e-04 | 466 | 46 | 6 | M13522 | |
| Coexpression | DESCARTES_ORGANOGENESIS_MEGAKARYOCYTES | 1.74e-04 | 159 | 46 | 4 | MM3657 | |
| Coexpression | GSE4984_GALECTIN1_VS_LPS_STIM_DC_UP | 1.74e-04 | 159 | 46 | 4 | M6502 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_k-means-cluster#3_top-relative-expression-ranked_1000 | 4.37e-06 | 225 | 41 | 6 | gudmap_developingGonad_e14.5_ ovary_1000_k3 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_k-means-cluster#1_top-relative-expression-ranked_500 | 4.27e-05 | 101 | 41 | 4 | gudmap_developingGonad_e14.5_ ovary_500_k1 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_k-means-cluster#2_top-relative-expression-ranked_1000 | 5.06e-05 | 210 | 41 | 5 | gudmap_developingGonad_e18.5_ovary_1000_k2 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_k-means-cluster#5_top-relative-expression-ranked_500 | 5.75e-05 | 109 | 41 | 4 | gudmap_developingGonad_e16.5_ovary_500_k5 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_k-means-cluster#2_top-relative-expression-ranked_1000 | 7.78e-05 | 230 | 41 | 5 | gudmap_developingGonad_e16.5_ovary_1000_k2 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_1000 | 1.25e-04 | 801 | 41 | 8 | gudmap_developingGonad_e14.5_ epididymis_1000 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.80e-04 | 275 | 41 | 5 | gudmap_developingGonad_e14.5_ epididymis_1000_k3 | |
| CoexpressionAtlas | DevelopingGonad_P2_ovary_emap-30224_k-means-cluster#5_top-relative-expression-ranked_1000 | 2.03e-04 | 151 | 41 | 4 | gudmap_developingGonad_P2_ovary_1000_k5 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_k-means-cluster#3_top-relative-expression-ranked_500 | 2.59e-04 | 161 | 41 | 4 | gudmap_developingGonad_e12.5_ovary_k3_500 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#3_top-relative-expression-ranked_500 | 2.94e-04 | 67 | 41 | 3 | gudmap_developingGonad_e18.5_epididymis_500_k3 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | RANBP1 TUBA1A LIN28B CHD9 ADGRV1 TUBA8 CNOT4 ZMYM5 ZNF292 HELLS | 3.57e-04 | 1459 | 41 | 10 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| ToppCell | (00)_Basal-(4)_1wkpi|(00)_Basal / shred by cell type and Timepoint | 4.74e-08 | 185 | 48 | 6 | bf82ba905e5eee1c39a2731702071d3de10a78b8 | |
| ToppCell | Calu_3-infected|Calu_3 / Cell line, Condition and Strain | 1.57e-06 | 183 | 48 | 5 | 8f7f5000645f24f20a8d7700c4df1f8953a1780b | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-classical_monocyte_proliferating-classical_monocyte_proliferating_l33-52|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.88e-06 | 190 | 48 | 5 | 638bebe200249ff6f7be764d89bd762da39ebaae | |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.25e-06 | 197 | 48 | 5 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 | |
| ToppCell | PCW_05-06|World / Celltypes from embryonic and fetal-stage human lung | 2.25e-06 | 197 | 48 | 5 | 1527261e2017113d8546d382a38acbb84699d03e | |
| ToppCell | Lymphoid-Lymphoid-B_cells_(cycle)|Lymphoid / shred on cell class and cell subclass (v4) | 3.52e-05 | 172 | 48 | 4 | f39822afcc35f0fbf68b8ffd1894e4b6c8d7a80c | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.68e-05 | 174 | 48 | 4 | 7b2f35add804981c7d588a996bdbca6ec11a1ca5 | |
| ToppCell | PND14-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD8_T-CD8_T_G2M|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.76e-05 | 175 | 48 | 4 | 8958c5c30437d20a4abd70d7527990f7e2a68b93 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Hematopoietic-Myeloid-Megakaryocyte|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.76e-05 | 175 | 48 | 4 | b85279b9efd72d7074c4226d50ce139a38c0e1c1 | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.85e-05 | 176 | 48 | 4 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.02e-05 | 178 | 48 | 4 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | C_00|World / shred on cell type and cluster | 4.11e-05 | 179 | 48 | 4 | da2dadc3266ffebd4a34ac61bfa05fddcadcde4c | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T6|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 4.11e-05 | 179 | 48 | 4 | 14fc8ccb6b215063d747643f47d780d2b237eb67 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-myocytic-SMC_(PART1/CAPN3+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.29e-05 | 181 | 48 | 4 | beb2771820956be8b190c0088ae3c4efdb53c897 | |
| ToppCell | megakaryocytic-Megakaryocyte|World / Lineage and Cell class | 4.77e-05 | 186 | 48 | 4 | acd15a169b6122b28cc99ef34de10701edcfedfe | |
| ToppCell | wk_08-11-Epithelial-Distal_epithelial-epi-tip_early|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 4.87e-05 | 187 | 48 | 4 | 5f9696097741b6e2b7b410c15c6b5ed883ed5eb2 | |
| ToppCell | wk_08-11-Epithelial-Distal_epithelial|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 4.87e-05 | 187 | 48 | 4 | eefffc2c6f7fa708a96e6bf07c6ce4e6c2e90847 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.98e-05 | 188 | 48 | 4 | c29aaae3c5bb7cd6b9b3defd4d27afde3af19ba0 | |
| ToppCell | 10x5'v1-week_17-19-Lymphocytic_B-B_lineage-pre_pro_B_progenitor|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 4.98e-05 | 188 | 48 | 4 | 9858940c616e43441644c5a3bea8d832ee4daf79 | |
| ToppCell | Control|World / Disease Group and Platelet Clusters | 4.98e-05 | 188 | 48 | 4 | f07654b215279abaf1c0882cdf41fbe31580a2ca | |
| ToppCell | Control-PLT_3|World / Disease Group and Platelet Clusters | 5.08e-05 | 189 | 48 | 4 | f65c261fe25479e900d5ed1a0d25a9dec302a57b | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.29e-05 | 191 | 48 | 4 | 60c986d2dcbc19d9338c03da6cb5e1d92fd48f8e | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.29e-05 | 191 | 48 | 4 | 09db184cb90fe282a14474d7217068c58092c6f8 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.29e-05 | 191 | 48 | 4 | 973117730d6ba5f127e7a0bfabfd0ff2ca7ac131 | |
| ToppCell | PBMC-Severe-Hematopoietic-Platelet-Platelet-plt_5|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.51e-05 | 193 | 48 | 4 | a2fb7482e79d6ce5b6b1d9d0c0811d1c58b4d85d | |
| ToppCell | PBMC-Severe-Hematopoietic-Platelet-Platelet-plt_5|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 5.51e-05 | 193 | 48 | 4 | 1d724ccb745cfc624119dd6003d53b84b17c94b0 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-OPC-like-OPC-like_Prolif-A|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.51e-05 | 193 | 48 | 4 | e477f5ddbb9d5878560998250ca0e1a5467953f4 | |
| ToppCell | 10x3'2.3-week_14-16-Lymphocytic_B-B_lineage-pro_B_progenitor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 5.62e-05 | 194 | 48 | 4 | f64da5f62e29253d60b9546edf734ba5c17daae1 | |
| ToppCell | E18.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_prolif|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.62e-05 | 194 | 48 | 4 | ae6d5cf4c825b29e677296df2c0985431c83b82e | |
| ToppCell | 356C-Myeloid-Dendritic|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 5.73e-05 | 195 | 48 | 4 | ba8b8831bd5f544f4e25f13949d04e164ecdcd12 | |
| ToppCell | CV-Mild-0|Mild / Virus stimulation, Condition and Cluster | 5.73e-05 | 195 | 48 | 4 | 2ffb9a9b6143bb404fe454cd939b573252bba6e9 | |
| ToppCell | ILEUM-non-inflamed-(1)_Highly_activated_T_cells|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 5.85e-05 | 196 | 48 | 4 | 6a415a2574bd84bd825a2bd6c8e3632a433ff7cf | |
| ToppCell | B_cell_maturation-CD34+_pro-B|World / Lineage and Cell class | 5.85e-05 | 196 | 48 | 4 | 4cb046883e56524963f6469ddb3b82c3c9853379 | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial-bulge_keratinocyte|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.85e-05 | 196 | 48 | 4 | 90edf61116ffcb4f8b6be3d0a05732d59b0a87d5 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Newborn-41|World / Primary Cells by Cluster | 5.85e-05 | 196 | 48 | 4 | dee0984cd63a1a2fdebb4421af48ab566a5b684e | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial-outer_bulge|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.85e-05 | 196 | 48 | 4 | c936014125b2ed5f796221b74acb77b8f8359875 | |
| ToppCell | CV-Severe-0|Severe / Virus stimulation, Condition and Cluster | 5.97e-05 | 197 | 48 | 4 | d13fc20b31ab6d9117437fba319c72f3a552858f | |
| ToppCell | Transverse-T_cell-Treg|T_cell / Region, Cell class and subclass | 5.97e-05 | 197 | 48 | 4 | b7a1637e4baadd657f6279f4aa96cd590c9cd8c9 | |
| ToppCell | severe-T/NK_proliferative|World / disease stage, cell group and cell class | 5.97e-05 | 197 | 48 | 4 | 6b7b068b103fd4f6ceda8e01f4dd39eefc3b3633 | |
| ToppCell | 10x3'2.3-week_14-16-Lymphocytic_B-B_lineage-pre_pro_B_progenitor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 6.08e-05 | 198 | 48 | 4 | 8aa4149d2c1cec73cfd654db093252ec8ec5ef68 | |
| ToppCell | myeloid-CD34+_Monoblast|myeloid / Lineage and Cell class | 6.08e-05 | 198 | 48 | 4 | e26b98a8380e693110a97d8e5a353998f8d67c6d | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.08e-05 | 198 | 48 | 4 | b258f672529fb2c03e62e2696d335043c4963280 | |
| ToppCell | control-Platelet|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 6.08e-05 | 198 | 48 | 4 | fc066f428340478605e7d9ff3c0c645c427c4876 | |
| ToppCell | severe-Lymphocytic-Prol._cells|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 6.08e-05 | 198 | 48 | 4 | 4d8591eabb543ed789f963b507a07c560c76a7c9 | |
| ToppCell | B_cell_maturation-CD34+_pro-B|B_cell_maturation / Lineage and Cell class | 6.08e-05 | 198 | 48 | 4 | 5737606e5e3dc56f11fdf70166caf4ba4a81bc9d | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-OPC-like-OPC-like_Prolif|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.08e-05 | 198 | 48 | 4 | 06888fe2d42ac66ac12157608becd42764e0d034 | |
| ToppCell | Non-neuronal-Dividing-Radial_Glia-vRG-11|World / Primary Cells by Cluster | 6.08e-05 | 198 | 48 | 4 | 672c6faeed54e1397e12c0aac1a5cbd19c684f06 | |
| ToppCell | CD8+_Memory_T_cell-FLU-2|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 6.08e-05 | 198 | 48 | 4 | 9813578a58cdedf68b57a0a5e3cf190c9c25a4cd | |
| ToppCell | wk_08-11-Mesenchymal-Fibroblast-Early_fibro|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 6.20e-05 | 199 | 48 | 4 | d67f5ae05daf942fb79f5b962021f37f4e275f4d | |
| ToppCell | 10x5'v1-week_12-13-Lymphocytic_B-B_lineage-pre_pro_B_progenitor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 6.20e-05 | 199 | 48 | 4 | 5478b78349b5d8d57f30bb650dcbd5fdb84283d6 | |
| ToppCell | remission-T/NK_proliferative|World / disease stage, cell group and cell class | 6.20e-05 | 199 | 48 | 4 | f305f3a454b7d2170429bad087480ccccca19acd | |
| ToppCell | PBMC-Convalescent-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 6.20e-05 | 199 | 48 | 4 | 4394dcd1809f49e9bada8f5e115d5123356eae3e | |
| ToppCell | remission-T/NK_proliferative|remission / disease stage, cell group and cell class | 6.20e-05 | 199 | 48 | 4 | 303a5fc43a48b05b6f2060d99eef4adc36f8d4e3 | |
| ToppCell | 10x5'v1-week_14-16-Lymphocytic_B-B_lineage-pre_pro_B_progenitor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 6.20e-05 | 199 | 48 | 4 | 8daf945fc93169b0a4fa3ef9f4a87eedd52e314a | |
| ToppCell | COVID-19_Convalescent-Lymphoid_T/NK-T/NK_proliferative|COVID-19_Convalescent / Disease group, lineage and cell class | 6.20e-05 | 199 | 48 | 4 | 893b78c661c529db07a5fcc3124d9b3d0f270fa5 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.20e-05 | 199 | 48 | 4 | c0ea391bb347b99b94b5d7f02612ede938986745 | |
| ToppCell | COVID-19_Convalescent-T/NK_proliferative|COVID-19_Convalescent / Disease condition and Cell class | 6.20e-05 | 199 | 48 | 4 | c608d953b852b67a4e36bd63d45f0deec3eefbd9 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.20e-05 | 199 | 48 | 4 | 5b18e18ddbf4bd53aa0d574d23092cb96da7f400 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-T/NK-Other_T|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.20e-05 | 199 | 48 | 4 | 6df65f4c2f9a125e0c7c4f597fefc05a97fc8831 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-T/NK-Other_T|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 6.20e-05 | 199 | 48 | 4 | cb229aa3eb7b1cc47e76711b8fc18fce88a5cf08 | |
| ToppCell | ILEUM-non-inflamed-(1)_T_cell-(1)_Highly_activated_T_cells|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 6.20e-05 | 199 | 48 | 4 | f9bf94ab6b5b134f5b98a65340843b147941ab58 | |
| ToppCell | normal_Lung-T/NK_cells-Undetermined|T/NK_cells / Location, Cell class and cell subclass | 6.20e-05 | 199 | 48 | 4 | 4142d5b1b20212508f95841fdac4efb7655616cb | |
| ToppCell | normal_Lymph_Node-T/NK_cells-Undetermined|normal_Lymph_Node / Location, Cell class and cell subclass | 6.20e-05 | 199 | 48 | 4 | cefcfe639a3396bccf2354ca605a1e18b964fbf2 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 6.20e-05 | 199 | 48 | 4 | 96af1f289552f38f2dfa181192eb3276f4c7d70b | |
| ToppCell | MS-IIF-Others-Platelet|IIF / Disease, condition lineage and cell class | 6.33e-05 | 200 | 48 | 4 | 2254319216f1c2e0a0f015ea530c1e6a55a92d5d | |
| ToppCell | critical-Epithelial-FOXN4+|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 6.33e-05 | 200 | 48 | 4 | f39db4250ce220a3eb58edee3f7fc3671701d46f | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Mesenchymal-immature_mesenchymal_cell-cycling_stromal|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.33e-05 | 200 | 48 | 4 | 1fbed5967fc1922efe4a98f5760ad74fce210c52 | |
| ToppCell | Severe-T/NK_proliferative|Severe / Disease group and Cell class | 6.33e-05 | 200 | 48 | 4 | 4723613a9f56bff422fc98722128d57b6adf3c5d | |
| ToppCell | ILEUM-inflamed-(1)_Highly_activated_T_cells|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 6.33e-05 | 200 | 48 | 4 | 6ff811fdfe49b5b0aea0e88fae80bfaaf40eb7c4 | |
| ToppCell | Severe-T/NK_proliferative|World / Disease group and Cell class | 6.33e-05 | 200 | 48 | 4 | 128d82eb4d5760adf872212d8e8b5787a889969f | |
| ToppCell | 343B-Myeloid-Dendritic-cDC_proliferating_1|Dendritic / Donor, Lineage, Cell class and subclass (all cells) | 6.33e-05 | 200 | 48 | 4 | 5f2fbd789cc16af411a01c3199583888b260ae91 | |
| ToppCell | COVID-19-COVID-19_Convalescent-Lymphocyte-T/NK-T/NK_proliferative|COVID-19_Convalescent / Disease, condition lineage and cell class | 6.33e-05 | 200 | 48 | 4 | 00538c4cbab5da00b3a366717d38a3ba5cfe3f65 | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Pericyte-Pericyte_3|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 6.33e-05 | 200 | 48 | 4 | a3a1e35934d676c39f917652e50c502cb2f613c1 | |
| ToppCell | tumor_Lung-T/NK_cells-Undetermined|T/NK_cells / Location, Cell class and cell subclass | 6.33e-05 | 200 | 48 | 4 | a1ef1b4824b2d56f6b2af15d698f58fc5590c392 | |
| ToppCell | 356C-Myeloid-Dendritic-cDC_proliferating_1|Dendritic / Donor, Lineage, Cell class and subclass (all cells) | 6.33e-05 | 200 | 48 | 4 | 548a0f486ab8745da107f2815914dbf873a6e3c8 | |
| ToppCell | myeloid-pro-cDC|myeloid / Lineage and Cell class | 6.33e-05 | 200 | 48 | 4 | 4aa2308eeb94e0bdff4e02eb9e45ba8837ae14bf | |
| ToppCell | COVID_vent-Lymphocytic-Proliferative_Lymphocyte-|COVID_vent / Disease condition, Lineage, Cell class and subclass | 6.33e-05 | 200 | 48 | 4 | 7e4c0db43a03ca11380a54f44a3cf1991e055b80 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-immature_mesenchymal_cell-cycling_stromal|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.33e-05 | 200 | 48 | 4 | 38665128b54f4a81b53c961427aed67bf4e2510b | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.33e-05 | 200 | 48 | 4 | 28c702449040ac15fe4e0c6340bb6f137e88539d | |
| ToppCell | (0)_NK_cells-(0)_NK_dividing|(0)_NK_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 6.33e-05 | 200 | 48 | 4 | 1a630bb327070ffcb111ec36bd8fd4be3627ca2a | |
| ToppCell | metastatic_Lymph_Node-T/NK_cells-Undetermined|T/NK_cells / Location, Cell class and cell subclass | 6.33e-05 | 200 | 48 | 4 | 9c2095dcf70f1288d55d0ff4a97efd4fd8d0c9ee | |
| ToppCell | COVID_vent-Lymphocytic-Proliferative_Lymphocyte|COVID_vent / Disease condition, Lineage, Cell class and subclass | 6.33e-05 | 200 | 48 | 4 | 9775ca7dedb76fcbb74f80f86b33c94e394c320a | |
| ToppCell | ILEUM-inflamed-(1)_T_cell-(1)_Highly_activated_T_cells|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 6.33e-05 | 200 | 48 | 4 | d92d3bc63a56a604d7b1d49e62d4304e5e4017f2 | |
| ToppCell | 5'-GW_trimst-1|5' / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.33e-05 | 200 | 48 | 4 | a4c6d0cccba7aee35eaedf29faff32b9494b6582 | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-2|TCGA-Ovary / Sample_Type by Project: Shred V9 | 2.59e-04 | 115 | 48 | 3 | ecc28d8413898b893f052914fd180de9468b70e4 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-OPC-like-OPC-like_Prolif-D|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.88e-04 | 132 | 48 | 3 | 634b69a20939ecb6aa9e00a22dfcd6ba781d4e73 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-AC-like-AC-like_Prolif|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.85e-04 | 152 | 48 | 3 | f748ee34167f79ecda116aa1914afab47403385a | |
| ToppCell | 10x3'2.3-week_17-19-Hematopoietic-HSC/MPP_and_pro-LMPP|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 6.31e-04 | 156 | 48 | 3 | 331b63bf4744ab494c3959436a8a0d8a1e4c0de4 | |
| ToppCell | 5'-Adult-SmallIntestine-Hematopoietic-T_cells-Treg|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.43e-04 | 157 | 48 | 3 | 2c767c526abcc8adea6ec4eb2cc333060bb213b5 | |
| ToppCell | facs-Trachea-nan-3m-Myeloid-lymphocyte_of_B_lineage|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.43e-04 | 157 | 48 | 3 | 0fecc14959c4c9efc19d5c06475a890e0a30f148 | |
| ToppCell | PCW_07-8.5-Hematologic_ErythroMegGranulo-Hem_ErythroMeg-im_megakaryocyte2_(17)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 6.54e-04 | 158 | 48 | 3 | f366c3532e7ef591e1051c172c92db41eb8c57f0 | |
| ToppCell | COVID-CD4-CD4_Treg|COVID / Condition, Cell_class and T cell subcluster | 6.67e-04 | 159 | 48 | 3 | 037cd97c41eb2f91fd3f69bbb3ffdfd6c0158410 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c06-TNF|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.79e-04 | 160 | 48 | 3 | 1a9329d8183296f36928bd9e96f10db9f04ce326 | |
| ToppCell | 356C-Lymphocytic-ILC-ILC-1|ILC / Donor, Lineage, Cell class and subclass (all cells) | 7.25e-04 | 37 | 48 | 2 | 5208860d6b87c6c6fbf6e6c262fb2efc712ec2d3 | |
| ToppCell | PND01-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON-iMON_prolif|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.42e-04 | 165 | 48 | 3 | ba68090d79e2243af2bdee0c27a32e65f540f8ac | |
| ToppCell | PCW_13-14-Hematologic_ErythroMegGranulo-Hem_ErythroMeg-im_megakaryocyte2_(17)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 7.42e-04 | 165 | 48 | 3 | d2ab667ff53f538b12ee4e07ea4b4d118600a228 | |
| ToppCell | Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Excitatory_Neuron.Gad1Gad2.Sgol2a_(Very_small_cluster)--|Striatum / BrainAtlas - Mouse McCarroll V32 | 7.95e-04 | 169 | 48 | 3 | 5375eb52ebadccb7bfff997a11985f23e81014d6 | |
| ToppCell | Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Excitatory_Neuron.Gad1Gad2.Sgol2a_(Very_small_cluster)|Striatum / BrainAtlas - Mouse McCarroll V32 | 7.95e-04 | 169 | 48 | 3 | c3bf0cb67f200d02d5a021754e9b2a68d23ea168 | |
| ToppCell | PND10-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC-ILC_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.95e-04 | 169 | 48 | 3 | 20fbf78382fb0ba9a63ab1aa0abc615476994ac5 | |
| ToppCell | Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Excitatory_Neuron.Gad1Gad2.Sgol2a_(Very_small_cluster)-|Striatum / BrainAtlas - Mouse McCarroll V32 | 7.95e-04 | 169 | 48 | 3 | 1c132d21255f5a5174ac38db4e91927f9093418e | |
| Computational | Neighborhood of ATRX | 1.17e-04 | 215 | 25 | 5 | MORF_ATRX | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 2.03e-04 | 50 | 25 | 3 | GAVISH_3CA_METAPROGRAM_FIBROBLASTS_MYOFIBROBLASTS | |
| Computational | Neighborhood of MT4 | 2.24e-04 | 247 | 25 | 5 | MORF_MT4 | |
| Drug | Epothilone D | 6.62e-14 | 12 | 49 | 6 | DB01873 | |
| Drug | Epothilone B | 6.62e-14 | 12 | 49 | 6 | DB03010 | |
| Drug | DTAF | 1.60e-10 | 37 | 49 | 6 | CID000123934 | |
| Drug | bromocolchicine | 7.42e-10 | 21 | 49 | 5 | CID000161518 | |
| Drug | Ustiloxin A | 7.42e-10 | 21 | 49 | 5 | CID000164454 | |
| Drug | SRI-3072 | 7.42e-10 | 21 | 49 | 5 | CID000493469 | |
| Drug | colchifoline | 7.42e-10 | 21 | 49 | 5 | CID000100132 | |
| Drug | 3,4,5-trimethoxyacetophenone | 9.59e-10 | 22 | 49 | 5 | CID000014345 | |
| Drug | AC1L1GIQ | 9.59e-10 | 22 | 49 | 5 | CID000003700 | |
| Drug | 2,4-dichlorobenzyl thiocyanate | 9.59e-10 | 22 | 49 | 5 | CID000098538 | |
| Drug | SureCN13401588 | 9.59e-10 | 22 | 49 | 5 | CID009897422 | |
| Drug | N-methyldemecolcine | 9.59e-10 | 22 | 49 | 5 | CID000023759 | |
| Drug | NSC-339672 | 9.59e-10 | 22 | 49 | 5 | CID000433930 | |
| Drug | IKP104 | 1.22e-09 | 23 | 49 | 5 | CID000130739 | |
| Drug | fluorescein-colchicine | 1.22e-09 | 23 | 49 | 5 | CID003035871 | |
| Drug | 3,4,5-trimethoxybenzaldehyde | 1.22e-09 | 23 | 49 | 5 | CID000006858 | |
| Drug | 3-demethylthiocolchicine | 1.22e-09 | 23 | 49 | 5 | CID000084076 | |
| Drug | 2,3,4-TCB | 1.22e-09 | 23 | 49 | 5 | CID000129239 | |
| Drug | AC1L2P05 | 1.22e-09 | 23 | 49 | 5 | CID000125688 | |
| Drug | 2,3,4-tabp | 1.22e-09 | 23 | 49 | 5 | CID000125548 | |
| Drug | NSC-373301 | 1.22e-09 | 23 | 49 | 5 | CID000341375 | |
| Drug | N-acetylcolchinol | 1.22e-09 | 23 | 49 | 5 | CID000097865 | |
| Drug | NSC355636 | 1.22e-09 | 23 | 49 | 5 | CID000100176 | |
| Drug | moscatilin | 1.54e-09 | 24 | 49 | 5 | CID000176096 | |
| Drug | parbendazole | 1.54e-09 | 24 | 49 | 5 | CID000026596 | |
| Drug | NSC-36768 | 1.54e-09 | 24 | 49 | 5 | CID000165441 | |
| Drug | deacetamidocolchicine | 1.54e-09 | 24 | 49 | 5 | CID000014995 | |
| Drug | tropolone methyl ether | 1.54e-09 | 24 | 49 | 5 | CID000016546 | |
| Drug | 7-epi-cephalomannine | 1.54e-09 | 24 | 49 | 5 | CID000330401 | |
| Drug | NABV | 1.54e-09 | 24 | 49 | 5 | CID000175959 | |
| Drug | colchicide | 1.54e-09 | 24 | 49 | 5 | CID000120712 | |
| Drug | AC1L4TG7 | 1.54e-09 | 24 | 49 | 5 | CID000163705 | |
| Drug | NSC 89199 | 1.73e-09 | 54 | 49 | 6 | CID000003268 | |
| Drug | NBD-colcemid | 1.92e-09 | 25 | 49 | 5 | CID000130594 | |
| Drug | mpMap | 1.92e-09 | 25 | 49 | 5 | CID000100806 | |
| Drug | AC1Q6P06 | 1.92e-09 | 25 | 49 | 5 | CID000160263 | |
| Drug | 2-methoxy-5-(2',3',4'-trimethoxyphenyl)tropone | 1.92e-09 | 25 | 49 | 5 | CID000043264 | |
| Drug | allocolchicine | 1.92e-09 | 25 | 49 | 5 | CID000196989 | |
| Drug | 1069C85 | 1.92e-09 | 25 | 49 | 5 | CID006918099 | |
| Drug | 55623-37-5 | 1.92e-09 | 25 | 49 | 5 | CID006438440 | |
| Drug | CA1P | 1.92e-09 | 25 | 49 | 5 | CID006918545 | |
| Drug | peloruside A | 1.92e-09 | 25 | 49 | 5 | CID006918506 | |
| Drug | NSC142227 | 1.92e-09 | 25 | 49 | 5 | CID000073427 | |
| Drug | MDL 27048 | 1.92e-09 | 25 | 49 | 5 | CID006439188 | |
| Drug | Taxane | 2.32e-09 | 103 | 49 | 7 | CID000108169 | |
| Drug | NSC527981 | 2.38e-09 | 26 | 49 | 5 | CID000352796 | |
| Drug | NSC332029 | 2.38e-09 | 26 | 49 | 5 | CID000100073 | |
| Drug | indibulin | 2.38e-09 | 26 | 49 | 5 | CID000002929 | |
| Drug | pironetin | 2.38e-09 | 26 | 49 | 5 | CID006438891 | |
| Drug | isaxonine | 2.38e-09 | 26 | 49 | 5 | CID000071169 | |
| Drug | AC1L1J4H | 2.92e-09 | 27 | 49 | 5 | CID000004862 | |
| Drug | NSC292222 | 2.92e-09 | 27 | 49 | 5 | CID000099957 | |
| Drug | dinitroanilines | 2.92e-09 | 27 | 49 | 5 | CID000136400 | |
| Drug | NSC D-669356 | 2.92e-09 | 27 | 49 | 5 | CID000178028 | |
| Drug | NSC 370147 | 3.54e-09 | 28 | 49 | 5 | CID000182762 | |
| Drug | NSC72302 | 3.54e-09 | 28 | 49 | 5 | CID000118078 | |
| Drug | bp U | 4.27e-09 | 29 | 49 | 5 | CID000368697 | |
| Drug | Aids106696 | 4.27e-09 | 29 | 49 | 5 | CID006475933 | |
| Drug | ddGDP | 4.27e-09 | 29 | 49 | 5 | CID000134739 | |
| Drug | oxibendazole | 4.27e-09 | 29 | 49 | 5 | CID000004622 | |
| Drug | AC1NBBHE | 5.12e-09 | 30 | 49 | 5 | CID004490620 | |
| Drug | eleutherobin | 5.12e-09 | 30 | 49 | 5 | CID006918335 | |
| Drug | azatoxin | 5.12e-09 | 30 | 49 | 5 | CID000125383 | |
| Drug | NSC617668 | 5.12e-09 | 30 | 49 | 5 | CID000357989 | |
| Drug | citostal | 5.12e-09 | 30 | 49 | 5 | CID000018991 | |
| Drug | thiocolchicine | 5.12e-09 | 30 | 49 | 5 | CID000017648 | |
| Drug | trans-1,2-diphenylethylene | 5.67e-09 | 117 | 49 | 7 | CID000011502 | |
| Drug | tropone | 6.10e-09 | 31 | 49 | 5 | CID000010881 | |
| Drug | NSC609395 | 6.10e-09 | 31 | 49 | 5 | CID005488798 | |
| Drug | amiprophosmethyl | 6.10e-09 | 31 | 49 | 5 | CID000100524 | |
| Drug | AC7700 | 6.10e-09 | 31 | 49 | 5 | CID006918404 | |
| Drug | 3,4-dimethylhexane-2,5-dione | 6.10e-09 | 31 | 49 | 5 | CID000032851 | |
| Drug | AC1L3V8I | 6.10e-09 | 31 | 49 | 5 | CID000122777 | |
| Drug | NSC332598 | 6.10e-09 | 31 | 49 | 5 | CID000615942 | |
| Drug | N,N'-ethylenebis(iodoacetamide | 6.10e-09 | 31 | 49 | 5 | CID000023678 | |
| Drug | AC1L1G95 | 7.21e-09 | 32 | 49 | 5 | CID000003583 | |
| Drug | E2-3,4-Q | 7.21e-09 | 32 | 49 | 5 | CID000067402 | |
| Drug | NSC153858 | 7.21e-09 | 32 | 49 | 5 | CID000547450 | |
| Drug | 2-demethylcolchicine | 7.21e-09 | 32 | 49 | 5 | CID000023757 | |
| Drug | CA4P | 8.49e-09 | 33 | 49 | 5 | CID000370232 | |
| Drug | taltobulin | 8.49e-09 | 33 | 49 | 5 | CID006918637 | |
| Drug | mebendazole | 8.49e-09 | 33 | 49 | 5 | CID000004030 | |
| Drug | triethyllead | 9.94e-09 | 34 | 49 | 5 | CID006328106 | |
| Drug | NSC376450 | 9.94e-09 | 34 | 49 | 5 | CID000005605 | |
| Drug | 2-phenyl-4-quinolone | 9.94e-09 | 34 | 49 | 5 | CID000161091 | |
| Drug | benomyl | 1.06e-08 | 128 | 49 | 7 | CID000028780 | |
| Drug | discodermolide | 1.16e-08 | 35 | 49 | 5 | CID000643668 | |
| Drug | AC1O5Y0F | 1.55e-08 | 37 | 49 | 5 | CID006442852 | |
| Drug | albendazole | 1.55e-08 | 37 | 49 | 5 | CID000002082 | |
| Drug | baccatin III | 1.55e-08 | 37 | 49 | 5 | CID000065366 | |
| Drug | laulimalide | 1.78e-08 | 38 | 49 | 5 | CID006918457 | |
| Drug | gnoscopine | 1.78e-08 | 38 | 49 | 5 | CID000004544 | |
| Drug | colchiceine | 1.78e-08 | 38 | 49 | 5 | CID000010156 | |
| Drug | LEO275 | 1.79e-08 | 79 | 49 | 6 | CID000018140 | |
| Drug | erianin | 2.04e-08 | 39 | 49 | 5 | CID000356759 | |
| Drug | Dolastatin 10 | 2.04e-08 | 39 | 49 | 5 | CID000100208 | |
| Drug | AC1L8GZ1 | 2.33e-08 | 40 | 49 | 5 | CID000381235 | |
| Drug | indanone | 2.65e-08 | 41 | 49 | 5 | CID000006735 | |
| Drug | amoebal | 2.65e-08 | 41 | 49 | 5 | CID000001985 | |
| Drug | lumicolchicine | 2.65e-08 | 41 | 49 | 5 | CID000072624 | |
| Disease | microlissencephaly (implicated_via_orthology) | 3.17e-23 | 8 | 49 | 8 | DOID:0112234 (implicated_via_orthology) | |
| Disease | lissencephaly 3 (implicated_via_orthology) | 3.17e-23 | 8 | 49 | 8 | DOID:0112232 (implicated_via_orthology) | |
| Disease | polymicrogyria (implicated_via_orthology) | 3.17e-23 | 8 | 49 | 8 | DOID:0080918 (implicated_via_orthology) | |
| Disease | lissencephaly (implicated_via_orthology) | 6.87e-17 | 27 | 49 | 8 | DOID:0050453 (implicated_via_orthology) | |
| Disease | CHARGE syndrome (implicated_via_orthology) | 1.50e-07 | 7 | 49 | 3 | DOID:0050834 (implicated_via_orthology) | |
| Disease | prostate cancer (is_marker_for) | 6.12e-06 | 156 | 49 | 5 | DOID:10283 (is_marker_for) | |
| Disease | MENTAL RETARDATION, AUTOSOMAL DOMINANT 12 | 2.69e-05 | 5 | 49 | 2 | C3281201 | |
| Disease | Neuroblastoma | 6.63e-05 | 47 | 49 | 3 | C0027819 | |
| Disease | opportunistic bacterial infectious disease (implicated_via_orthology) | 9.65e-05 | 9 | 49 | 2 | DOID:0050340 (implicated_via_orthology) | |
| Disease | Macrocephaly | 1.47e-04 | 11 | 49 | 2 | C0221355 | |
| Disease | Coffin-Siris syndrome | 2.08e-04 | 13 | 49 | 2 | C0265338 | |
| Disease | congenital heart disease (implicated_via_orthology) | 2.09e-04 | 69 | 49 | 3 | DOID:1682 (implicated_via_orthology) | |
| Disease | diet measurement | 3.07e-04 | 1049 | 49 | 8 | EFO_0008111 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 3.11e-04 | 195 | 49 | 4 | DOID:1574 (implicated_via_orthology) | |
| Disease | Periodontal Pocket | 7.91e-04 | 25 | 49 | 2 | EFO_1001393 | |
| Disease | Sezary Syndrome | 9.23e-04 | 27 | 49 | 2 | C0036920 | |
| Disease | Cocaine-Related Disorders | 9.80e-04 | 117 | 49 | 3 | C0236736 | |
| Disease | Subfertility, Female | 9.93e-04 | 28 | 49 | 2 | C0341869 | |
| Disease | Sterility, Postpartum | 9.93e-04 | 28 | 49 | 2 | C0038279 | |
| Disease | Female sterility | 9.93e-04 | 28 | 49 | 2 | C0917730 | |
| Disease | Female infertility | 9.93e-04 | 28 | 49 | 2 | C0021361 | |
| Disease | Neoplasm of uncertain or unknown behavior of ovary | 1.07e-03 | 29 | 49 | 2 | C0496920 | |
| Disease | Ovarian Carcinoma | 1.14e-03 | 30 | 49 | 2 | C0029925 | |
| Disease | Cocaine Abuse | 1.24e-03 | 127 | 49 | 3 | C0009171 | |
| Disease | Cocaine Dependence | 1.61e-03 | 139 | 49 | 3 | C0600427 | |
| Disease | stroke | 1.78e-03 | 144 | 49 | 3 | EFO_0000712 | |
| Disease | body height at birth | 2.02e-03 | 40 | 49 | 2 | EFO_0006784 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 2.08e-03 | 152 | 49 | 3 | DOID:0060041 (implicated_via_orthology) | |
| Disease | lipid measurement, high density lipoprotein cholesterol measurement | 2.19e-03 | 330 | 49 | 4 | EFO_0004529, EFO_0004612 | |
| Disease | multiple sclerosis | 2.99e-03 | 594 | 49 | 5 | MONDO_0005301 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| NTMMELRKCCNHPYL | 1086 | Q9HCK8 | |
| VYFILHNQMCCPMKA | 6151 | Q8WXG9 | |
| HNQMCCPMKASYTVE | 6156 | Q8WXG9 | |
| LKICANHYITPMMEL | 96 | P43487 | |
| ICNPLQYHIMMSKKL | 126 | Q8NHB8 | |
| QNIMMLLRKCCNHPY | 561 | Q9NRZ9 | |
| PQPKKCHYCQSIMHM | 146 | Q6ZN17 | |
| GMEHLYSMKCKNVVP | 521 | P03372 | |
| YMAICKPLHELITMN | 151 | Q8NGL6 | |
| KPLHYMTIMNQCVCA | 126 | A6NHA9 | |
| KPLHYMAIMNQRMCG | 126 | Q8NH49 | |
| ILQYMKMCVSEAPLH | 1111 | Q96J66 | |
| MKPHCAICTLLMPYH | 641 | Q9H3R0 | |
| EQRMTLPCMYDQCKH | 631 | P04150 | |
| LPCMYDQCKHMLYVS | 636 | P04150 | |
| ICNPLQYHIMMSKKL | 126 | Q8NHB7 | |
| SKNVLLACPMNMYPH | 411 | P20393 | |
| KPTYCNFCHIMLMGV | 281 | P49619 | |
| TMMELRKCCNHPYLI | 1136 | Q3L8U1 | |
| SKCAYLPKMMTLHQQ | 566 | Q14241 | |
| NTMMELRKCCNHPYL | 736 | Q8TD26 | |
| IMMDLKKCCNHPYLF | 1021 | Q12873 | |
| NMMFIKTCACHYNCP | 316 | P29279 | |
| GISPHVCKLMKICMN | 416 | Q13418 | |
| TLYMVNNAVPQCCHM | 611 | Q9P203 | |
| PHKMLMAGIQCCALL | 331 | Q6ZQY3 | |
| YMHKVMNDLPSCPCS | 311 | B1AKI9 | |
| CMAICKPLHYTIIMS | 121 | A6NL08 | |
| ICHPLNYQMIMNKGV | 126 | Q8NH74 | |
| QVMGMAYPSCHSCVL | 266 | Q9NYV8 | |
| CDRSHCMPYSNKMQL | 191 | Q8IWZ5 | |
| MNTIMQLRKICNHPY | 1006 | P51531 | |
| KVMCHIMPFLQCVSV | 111 | Q15761 | |
| HLLGMMSCCLNPILY | 411 | Q15761 | |
| MNTIMQLRKICNHPY | 1036 | P51532 | |
| KNMQCPKPDCMYLHE | 201 | O95628 | |
| QMVKCDPRHGKYMAC | 301 | P0DPH8 | |
| MRMHTGEKPYVCKQC | 371 | Q15935 | |
| QMVKCDPRHGKYMAC | 301 | P0DPH7 | |
| LQMHCGSKPYICIQM | 741 | O60281 | |
| MMPFCHNIINISCVK | 1 | Q96RJ0 | |
| QMMHTGEKPYKCNEC | 696 | Q6ZN19 | |
| IMNCCEHCGEYMPSK | 376 | Q9UJ78 | |
| PYPMLEHCNNMCTMR | 201 | O43149 | |
| QMVKCDPRHGKYMAC | 301 | Q71U36 | |
| QMVKCDPRHGKYMAC | 301 | Q6PEY2 | |
| KMHMRCHTGEKPYQC | 1026 | Q8NAP3 | |
| QMVKCDPRHGKYMAC | 301 | P68363 | |
| QMVKCDPRHGKYMAC | 301 | Q9BQE3 | |
| QMVKCDPRHGKYMAC | 301 | Q9NY65 | |
| QMVKCDPRHGKYMAC | 301 | P68366 | |
| MIMHSGNPAYKCTIC | 241 | Q96BR6 |